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Abstract
In this dissertation, I consider inference about target parameters under three
distinct study designs. The first design, considered in my first paper, is the
comprehensive cohort design, whereby patients are first offered enrollment into
a randomized trial and if they refuse are offered enrollment into an observational
study where they can select their own treatment. In this paper, I develop
estimators for two estimands: the comprehensive cohort causal effect and the
randomized trial causal effect. The second design, considered in my second
paper, is the outcome-dependent two-phase sampling design, where in the first
stage inexpensive covariates, treatment choice and outcomes are collected on all
patients sampled from a target population and in the second stage expensive
covariates, needed to adjust for non-random treatment choice, are collected
on a subset of patients. I develop an optimal algorithm for sampling patients
at the second stage, where optimality is based on minimizing the asymptotic
variance of an estimator of a causal estimand subject to second stage sample
size constraints. The third paper applies to any study design where the observed
data for individuals can be viewed as independent and identically draws from
some distribution. In this paper, we develop a fast double bootstrap procedure
for constructing two-sided equal-tailed confidence intervals for estimands which
have asymptotically linear estimators. The underlying theme behind all the the
papers is the use of influence functions to derive and represent asymptotically
linear estimators of target parameters of interest.
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In statistical inference based on a random sample of observations, the difference
between an estimator and the true value of the target parameter of interest of-
ten behaves asymptotically like an average (over observations) of a function of
the individual observations. An estimator with this feature is called asymptot-
ically linear and the function is referred to as the influence function (Hampel,
1974). The term influence function is used because to the first order it quantifies
the influence of a single observation on the corresponding estimator. Influence
functions are useful, as the asymptotic behavior of an asymptotic linear esti-
mator can be approximated, using central limit theory, by considering only its
influence function. For example, the asymptotic variance of an estimator can
be estimated by an estimate of the variance of the influence function. Further-
more, it is possible to characterize the collection of all influence functions for
a target parameter from a statistical model and they can be used to construct
asymptotically linear estimators (Tsiatis, 2006).
In this dissertation, we develop statistical methods to address a range of
issues related to different sampling designs. The influence function serves as a
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common tool used in our statistical developments. The following three sections
introduce and motivate the three topics tackled in this thesis.
1.1 Causal inference for comprehensive cohort
studies
In a comprehensive cohort study of two competing treatments (A,B), clinically
eligible individuals are first asked to enroll in a randomized trial and, if they
refuse, are then asked to enroll in a parallel observational study in which they
can choose treatment according to their own preference. The project is moti-
vated by an ongoing comprehensive cohort study, the FIXIT study, to assess
fixation strategies for severe open tibia fractures. The FIXIT study is a multi-
center, prospective phase III randomized clinical trial, with patients who refuse
randomization being eligible to enroll in a prospective observational study. The
study will compare the rate of re-hospitalization for major limb complications
under two standard options of treatment: internal fixation with a nail or plate
vs. external ring fixation. One of the primary aims is to draw inference using
combined information from the randomized trial and the parallel observational
study.
We consider estimation of two estimands: (1) comprehensive cohort causal
effect – the difference in mean potential outcomes had all patients in the com-
prehensive cohort received treatment A vs. treatment B and (2) randomized
trial causal effect – the difference in mean potential outcomes had all patients
enrolled in the randomized trial received treatment A vs. treatment B. We
study the class of influence functions under different modeling restrictions in
search of efficient and robust estimators. For the comprehensive cohort causal
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effect, we introduce two estimators: inverse probability weighted and locally ef-
ficient/doubly robust. For the randomized trial causal effect, we introduce four
estimators: simple inverse probability weighted, simple robust, enriched doubly
robust and locally efficient.
We evaluate finite sample performance of these estimators in a simulation
study. We also illustrate our methodology using data from the BARI (By-
pass Angioplasty Revascularization Investigation) randomized trial and obser-
vational registry to evaluate the effect of percutaneous transluminal coronary
balloon angioplasty (PTCA) versus coronary artery bypass grafting (CABG) on
5-year mortality.
1.2 Optimal outcome-dependent two-phase sam-
pling
We investigate an optimal outcome-dependent two-phase sampling design to
estimate the causal effect of a treatment from observational data. In the first
phase, information from all subjects in the study is obtained on treatment,
outcome and a set of covariates which are relatively inexpensive to measure. In
the second phase, subjects are stratified based on the first phase information,
a random subsample of individuals (i.e. validation sample) is drawn from each
stratum (with known stratum-specific sampling probabilities), and a rich set of
expensive covariates are measured on the validation sample. The causal effect
of interest is then estimated based on data collected in both phases.
This topic was motivated by a consulting project in which a pharmaceutical
company was interested in comparing the efficacy of their drug to a competitor’s
drug based on data from a very large healthcare database. The problem was
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that the key covariates (e.g., co-morbidities) needed to adjust for confound-
ing required an expensive medical record review process, whereas treatment,
outcome and basic covariates (e.g., age, gender) were readily available. The
pharmaceutical company wanted to know how to select patients for medical
record review.
Given the first phase data and a specified estimator of the causal effect,
we propose an optimal choice for the stratum-specific sampling probabilities in
the second phase by minimizing the variance of the estimator given validation
sample size constraints. We consider four estimators of the causal effect: simple
inverse probability weighted and enriched doubly robust each with sampling
probabilities known and with sampling probabilities estimated. We investigate
the general form of the influence functions for these estimators, to capture the
relationship between the within strata sampling fractions and the asymptotic
variance of the resulting estimator.
We present a detailed simulation study, designed to evaluate the finite sample
performance of these estimators under different validation sampling schemes.
We also illustrate our methods using data from a large observational study
to estimate the causal effect of right heart catheterization (RHC) on 30-day
survival under various hypothetical two-phase sampling schemes.
1.3 Influence function based fast double boot-
strap confidence intervals
For small to medium sized samples, equal-tailed two-sided confidence intervals
based on asymptotic normal approximation or bootstrap methods such as the
percentile bootstrap and studentized bootstrap, often fail to provide accurate
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coverage. Iterated bootstrap methods have been proposed to reduce the cov-
erage error by calibrating the nominal level using nested levels of resampling,
which in practice can be extremely computationally intensive.
This topic was motivated by a project where sensitivity analysis methods
were being developed for estimating treatment effects from clinical trials in the
presence of potentially informative missing data. In simulations, Wald-based
confidence intervals based on influence functions and single layer bootstrap con-
fidence intervals were seen to have poor coverage in small to moderate sized
samples. A double bootstrap solution was considered to be computationally
intensive. A natural question is whether there is a fast alternative. This paper
is a first step at addressing this problem.
Specifically, we propose a fast double bootstrap procedure for constructing
confidence intervals for a parameter whose estimator is defined as the solution
to an estimating function involving nuisance parameters. Our resampling pro-
cess directly exploits the influence function representation, and a saddle-point
approximation approach is employed to avoid inner-level resamplings. The re-
sulting equal-tailed two-sided confidence intervals are shown to be at least third
order accurate, i.e. better coverage accuracy than single layer bootstrap inter-
vals, yet without extra computational burden. A simulation study demonstrates
that, compared to other methods, our fast double bootstrap interval has desir-
able empirical coverage for small to medium sample sizes.
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1.4 Overview of dissertation
This dissertation is organized as follows. Chapters 2-4 provide the details of
the topics described in Sections 1.1-1.3 above. In each chapter, we present
(i) an introduction to the statistical problem, review of the existing statistical
methodology, and the relevance of our contribution; (ii) a description of the
theoretical framework and our statistical methods; (iii) numerical results from
simulation study and/or real data analysis; and (iv) a summary of conclusions,
with a discussion of limitations and future research directions. Chapter 5 is






Randomized controlled trials (RCTs) are considered to be the gold standard in
evaluating the effect of treatments, primarily because the randomization pro-
cess probabilistically ensures that treatment groups are balanced with respect to
measured and unmeasured prognostic factors. A well conducted RCT is said to
have high internal validity. However, its external validity (i.e., generalizability
of results to a broader population) is not guaranteed. This is because eligible
patients who agree to enroll in an RCT may be not be a representative sample of
all eligible patients. Due to the the tension between internal and external valid-
ity, researchers have recommended that all clinically eligible patients, agreeing
to randomization or not, should be enrolled and studied (Fielding et al., 1999).
Olschewski and Scheurlen (1985) introduced the comprehensive cohort study
(CCS) design for evaluating competing treatments (say, A and B) in which
clinically eligible participants are first asked to enroll in a randomized trial and,
if they refuse, are then asked to enroll in a parallel observational study (OBS) in
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which they can choose treatment according to their own preference (see Figure
2.1(a)). Since the CCS design incorporates patient preference, it has also been
referred to as a (partially randomized) patient preference trial (Brewin and
Bradley, 1989; Brocklehurst, 1997; Torgerson and Sibbald, 1998).
King et al. (2005) conducted a systematic review of randomized trials incor-
porating participants’ preferences published during 1966-2004. In addition to
the CCS design, they examined the two-stage randomized (TSR) design pro-
posed by Rücker (1989) and Wennberg et al. (1993) (see Figure 2.1(b)). In
contrast to the CCS design, the TSR design has a first stage randomization
into either the RCT or OBS. Of the 32 trials identified by King et al. (2005),
27 (84%) were CCS designs.
In this paper, we focus on inference about treatment effects from a CCS,
where the primary outcome (continuous or binary) is to be measured at a fixed
point in time after treatment assignment. In particular, we are interested in
drawing inference about two causal estimands: comprehensive cohort causal
effect – the difference in mean potential outcomes had all patients in the com-
prehensive cohort received treatment A vs. treatment B, and randomized trial
causal effect – the difference in mean potential outcomes had all patients en-
rolled in the randomized trial received treatment A vs. treatment B. The first
estimand has greater external validity than the second. Our goal is to use all
the available data to draw inference about these estimands.
Marcus (1997) has investigated the difference between the two estimands in
a CCS design, called “non-consent bias”, and suggested adjusting for baseline
covariates to account for the difference between the RCT population and the
comprehensive cohort. Otherwise, most of the literature that describes methods
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for analyzing treatments effects from a CCS doesn’t directly address our causal
objectives. Rather, the main focus is on estimating treatment effects separately
for the RCT and OBS (see, for example, Olschewski et al. (1992), Henshaw
et al. (1993), Nicolaides et al. (1994), Schmoor et al. (1996), King et al. (1997),
Detre et al. (1999), Bedi et al. (2000), Brooks et al. (2000), Kerry et al. (2000),
King et al. (2000), Rovers et al. (2001), Jensen et al. (2003), Schmoor et al.
(2008)), with some adjusting for confounding in the OBS. With the exception
of Olschewski et al. (1992), King et al. (1997) and Brooks et al. (2000), there is
no borrowing of information between the RCT and OBS.
In this paper, we derive, using semiparametric theory (Tsiatis, 2006), esti-
mators of the comprehensive cohort and randomized trial causal effects under
a set of unconfoundedness assumptions regarding randomization consent sta-
tus and treatment assignment. In Section 2.2, we introduce notation, data
structure, and main assumptions. In Section 2.3, we propose two estimators for
the comprehensive cohort causal effect: inverse probability weighted (CC-IPW),
locally efficient and doubly robust (CC-LEDR); and four estimators for the ran-
domized trial causal effect: simple inverse probability weighted (RCT-SIPW),
simple robust (RCT-SR), enriched doubly robust (RCT-EDR) and locally effi-
cient (RCT-LE). Section 2.4 presents a simulation study that evaluates the finite
sample performance of our proposed estimators. In Section 2.5, we illustrate
our methods using data from the BARI (Bypass Angioplasty Revascularization
Investigation) randomized trial and observational registry to evaluate the ef-
fect of percutaneous transluminal coronary balloon angioplasty (PTCA) versus
coronary artery bypass grafting (CABG) on 5-year mortality. The last section

































(b) Two-stage randomized (TSR) design (†In Rücker (1989) design, participants random-
ized to OBS in the first stage who do not have a strong preference for a treatment are
randomized to a treatment.)
Figure 2.1: Flowchart of CSS and TSR study designs for comparing two
treatments A vs. B (Rz: randomization)
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2.2 Notation and framework
Let X denote a vector of baseline covariates and let Y be the observed outcome
(continuous or binary). Let R denote the randomization consent indicator (1
for RCT, 0 for OBS) and let T denote the treatment assignment indicator (1
for treatment A, 0 for treatment B). The observed data for an individual are
O = (X ′, Y, R, T )′. We assume that we observe n independent and identically
distributed copies of O. Let Y1 and Y0 denote an eligible patient’s potential
outcome under treatment A and B, respectively.
Our goal is to use the observed data to draw inference about the compre-
hensive cohort causal effect:




and the randomized trial causal effect:
∆RCT = E[Y1|R = 1]︸ ︷︷ ︸
µ∗11
−E[Y0|R = 1]︸ ︷︷ ︸
µ∗10
To identify ∆CC and ∆RCT from the observed data, we posit assumptions
sufficient for identification of µ∗t and µ
∗
1t (t = 0, 1). We make the stable unit
treatment value assumption as discussed in Rubin (1986), which states that the
potential outcomes of a patient is unaffected by the randomization consent and
treatment decision of any other patient. We make the consistency assumption
that states that the observed outcome under the treatment actually received is
equal to the potential outcome under that treatment (i.e., Y = TY1+(1−T )Y0).
Further, we assume
11
(A1). Conditional unconfoundedness of consent to randomization:
R⊥ (Y1, Y0)|X
(A2). Unconfoundedness of treatment assignment within the RCT :
T⊥ (Y1, Y0, X)|R = 1
(A3). Conditional unconfoundedness of treatment selection within the OBS :
T⊥ (Y1, Y0)|R = 0, X
Assumption (A1) implies that, conditional on (X, Y1, Y0), consent to randomiza-
tion is a Bernoulli process with the consent probability λ∗(X) = P [R = 1|X],
i.e. only depending upon the covariates X. Assumptions (A2) and (A3) indi-
cate that, conditional on (X, Y1, Y0, R), treatment selection is a Bernoulli process
with the selection probability π∗t (R,X) = P [T = t|R,X] and does not depend
on X when R = 1. We further assume that λ∗(X) and π∗t (R,X) are strictly
greater than 0 and less than 1 for all X and t.
For convenience, see Table 2.1 for a complete list of our notation, with some
additional symbols used in the estimation section.
2.3 Estimation
Our overarching estimation strategy proceeds by first finding unbiased estimat-
ing functions for µ∗t and µ
∗
1t. These estimating functions depend on nuisance
functions. We propose estimators for µ∗t and µ
∗
1t by solving empirical versions of
these estimating functions with estimators plugged-in for the nuisance functions.
We also determine the asymptotic properties of our proposed estimators.
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Table 2.1: Notation
Symbol Description (t = 0, 1.)
R Randomization consent indicator (1 for RCT, 0 for OBS)
T Treatment indicator (1 for A, 0 for B)
X Baseline covariates
Yt Potential outcome under treatment t
Y Observed outcome
µ∗t E[Yt]








λ∗ P [R = 1]
λ∗(X) P [R = 1|X]
π∗t (R,X) P [T = t|R,X]
ρ∗t P [T = t, R = 1]
2.3.1 Inverse probability weighted estimators
Consider the following the inverse probability weighted estimating functions:
UCC−IPWt {O;µt, πt(R,X)} =
I{T = t}
πt(R,X)
(Y − µt) (2.1)
URCT−SIPW1t (O;µ1t, ρt) =
I{T = t}R
ρt
(Y − µ1t) (2.2)
for µ∗t and µ
∗
1t, respectively. We label (2.1) as the inverse probability weighted
(IPW) estimating function, and (2.2) as the simple inverse probability weighted
(SIPW) estimating function, where the word “simple” is added to reflect the
use of information only from the RCT. Under our assumptions, both functions
can be shown to have mean 0 (i.e., unbiased) when evaluated at the truth
(µ∗t , π
∗







In order to draw
√
n−inference about µ∗t based on (2.1) , we need an estimator
of π∗t (R,X) converging at a rate faster than n
1/4. To proceed, we consider a
fully parametric model for π∗t (R,X) = πt(R,X;α
∗), where α∗ denotes the true
value of the model parameter (vector) α. We shall assume the following logistic
model
logit {π1(R,X;α∗)} = l(R,X;α∗)
= Rα∗1 + (1−R)l0(X;α∗0) (Mπ)
where α1 is a scalar parameter, l0(X;α0) is a specified function of X and the




0 are the true values of α1 and α0, respectively,
and α∗ = (α∗1, α
∗′
0 )















1 + exp {l0(X;α∗0)}
Based on this logistic model Mπ , α∗ can be estimated as the solution α̂ to
En [Sα(T,R,X;α)] = 0,


















has mean 0 when evaluated at (µ∗t , α
∗). Let µ̂CC−IPWt denote the solution to
(2.3). Under correct specification of model Mπ and some additional regularity
conditions, it can be shown that µ̂IPWt is a regular and asymptotically linear





































the same as IFCC−IPWt (O;µt, α) except that the expectations are replaced with
empirical averages.
RCT-SIPW
To draw inference about µ∗1t based on (2.2), we estimate ρ
∗
t = P [T = t, R = 1]
by
ρ̂t := En [I{T = t, R = 1}]















t ), and we can es-






2.3.2 Alternative estimators under Mπ
The inverse probability weighted estimators discussed above are not efficient.
Based upon the semiparametric theory of inference for coarsened data (Tsiatis,
2006), we can derive the most efficient influence function (corresponding to the
RAL estimator with the smallest variance) by projecting the influence function
of any RAL estimator onto the semiparametric tangent space.
We consider the semiparametric model Pπ which imposes restrictions on the
distribution of the observed data through assumptions (A1) – (A3) and model
Mπ. The semiparametric tangent space for this model (T Oπ ) is defined as the
mean square closure of the linear space of score functions from all parametric
submodels contained in the model. To proceed with the desired projection, we
show in Appendix I that the orthogonal complement of T Oπ has the form:
T O,⊥π = Λh ⊕ Λb ⊕ Λa, (2.4)
where ⊕ denotes the direct sum and
Λh = Λh0 ⊕ Λh1
Λhτ = {φ2τ{O;α∗, λ∗(X), hτ} : E [hτ (X, Yτ )|X] = 0} τ = 0, 1.
Λb =
{










Λa = {φ4{O;α∗1, λ∗(X), a} : E [a(X)] = 0}
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with





− I{T = τ}(1−R)
πτ (0, X;α∗0) {1− λ∗(X)}
}
hτ (X, Yτ )
φ3{O;α∗0, λ∗(X), b} =
1−R
1− λ∗(X)













Importantly, Λh0 ,Λh1 ,Λb,Λa are pairwise orthogonal to each other. Appendix
III shows how to project an arbitrary function of the observed data (with mean
zero and finite variance) onto each of these spaces. Based on these results,
we can derive the projection of the influence functions for CC-IPW and CC-
SIPW estimators onto the semiparametric tangent space T Oπ , for more efficient




Efficient and robust estimator for µ∗t (CC-LEDR)
As mentioned above, the most efficient influence function for estimating µ∗t
under the semiparametric model Pπ is the projection
























































− I{T = t}(1−R)
πt(0, X;α∗0) {1− λ∗(X)}
}

















where Π[·|·] is the projection operator. Treated as an estimating function, (2.5)
has mean 0 when evaluated at {µ∗t , α∗, λ∗(X), µ∗t (X)}.
To draw
√
n−inference about µ∗t , we consider parametric models: λ∗(X) =
λ(X; γ∗) and µ∗t (X) = µt(X; η
∗
t ), where γ
∗, η∗t denote the true values of the
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model parameter vectors γ, ηt respectively. For the randomization consent in-
dicator, we posit the logistic model
logit {λ(X; γ∗)} = q(X; γ∗) (Mλ)
where q(X; γ∗) is a specified function of X and γ. In this model, γ∗ can be
estimated as the solution γ̂ to






is the associated score function. The parameter η∗t can be estimated using an
estimating function of the form:
I{T = t} at(X; ηt){Y − µt(X; ηt)}︸ ︷︷ ︸
Sηt (Y,X;ηt)
where at(X; ηt) is a specified function of X and ηt that is of the same dimen-
sion as ηt. Note that this estimating function has mean zero at η
∗
t because
assumptions (A1) – (A3) imply that
T⊥ (Y1, Y0)|X
We estimate η∗t as the solution η̂t to
En [I{T = t}Sηt(Y,X; ηt)] = 0.
Consequently, we may replace α∗, λ∗(X), µ∗t (X) in (2.5) with α̂, λ(X; γ̂) and
µt(X; η̂t) respectively, and define the estimator µ̂
CC−LEDR
t as the solution to
En
[




We name (2.5) the locally efficient doubly robust (LEDR) influence function,
for the following reasons. First, it’s not only the most efficient influence function
under the restrictions of assumptions (A1) – (A3) and model Mπ, but also
the most efficient under the additional model restriction Mλ, which will be




φCC−LEDRt {O;µ∗t , α∗, λ(X; γ∗), µt(X; η̃t)}
]
= 0 for any η̃t;
(ii). E
[
φCC−LEDRt {O;µ∗t , α̃, λ(X; γ̃), µt(X; η∗t )}
]
= 0 for any α̃, γ̃;
and thus is said to be “doubly robust” in the sense that the resulting estimator
µ̂CC−LEDRt will be consistent and asymptotically normal when either the joint
model (Mπ ∩ Mλ) or the model for µ∗t (X) is correctly specified. As a result,
the influence function for µ̂CC−LEDRt can be shown to be
IFCC-LEDRt (O;µ
∗
t , α̃, γ̃, η̃t)
= φCC-LEDRt {O;µ∗t , α̃, λ(X; γ̃), µt(X; η̃t)}
− E
[



























I{T = t}∂Sηt(Y,X; η̃t)
∂η′t
]−1
× I{T = t}Sηt(Y,X; η̃t),
(2.6)
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where either (α̃′, γ̃′)′ = (α∗′, γ∗′)′ (the models for π∗t (R,X) and λ
∗(X) are cor-
rectly specified) or η̃t = η
∗
t (the model for µ
∗
t (X) is correctly specified). Further,
the second and third terms on the right hand side of equation (2.6) vanish if
η̃t = η
∗
t , while the fourth term vanishes if (α̃
′, γ̃′)′ = (α∗′, γ∗′)′. The asymptotic




t , α̃, γ̃, η̃t)
2], which is





t , α̂, γ̂, η̂t)
2], where ÎF
CC−LEDR
t (O;µt, α, γ, ηt) is
the same as IFCC−LEDRt (O;µt, α, γ, ηt) except that the expectations are replaced
by empirical averages.
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Enriched doubly-robust estimator of µ∗1t (RCT-EDR)
Using semiparametric theory, the most efficient influence function for estimating
µ∗1t under the semiparametric model Pπ is the projection































































− I{T = t}(1−R)
πt(0, X;α∗0) {1− λ∗(X)}
}{










πt(0, X;α∗0) {1− λ∗(X)}
}−1
, (2.7)
Treated as an estimating function, (2.7) has mean zero when evaluated at
the truth {µ∗1t, ρ∗t , α∗, λ∗(X), µ∗t (X)}. As above, we employ parametric mod-
els λ∗(X) = λ(X; γ∗) and µ∗t (X) = µt(X; η
∗
t ). We obtain the RAL estimator
µ̂RCT−EDR1t as the solution to
En
[
φRCT−EDR1t {O;µ1t, ρ̂t, α̂, λ(X; γ̂), µt(X; η̂t)}
]
= 0,
with the estimators ρ̂t, α̂, γ̂, η̂t defined previously.
22
We call (2.7) the enriched doubly robust (EDR) influence function, with
the word “enriched” to emphasize the usage of additional information from the
OBS. This is in contrast to µ̂RCT−SIPW1t which only used data from the RCT.
In addition, the influence function (2.7) also has the same “doubly robustness”
property of CC-LEDR influence function (2.5). That is, µ̂RCT−EDR1t will be con-
sistent and asymptotically normal when either the joint model (Mπ ∩ Mλ) or






t , α̃, γ̃, η̃t)
= φRCT-EDR1t {O;µ∗1t, ρ∗t , α̃, λ(X; γ̃), µt(X; η̃t)}
− E
[



























I{T = t}∂Sηt(Y,X; η̃t)
∂η′t
]−1
× I{T = t}Sηt(Y,X; η̃t),
(2.8)
where either (α̃′, γ̃′)′ = (α∗′, γ∗′)′ (the models for π∗t (R,X) and λ
∗(X) are cor-
rectly specified) or η̃t = η
∗
t (the model for µ
∗
t (X) is correctly specified). Again,
on the right hand side of equation (2.8), the second and third terms vanish if η̃t =
η∗t , while the fourth term vanishes if (α̃
′, γ̃′)′ = (α∗′, γ∗′)′. Similarly, the “doubly






t , α̃, γ̃, η̃t)
2],
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1t (O;µ1t, ρt, α, γ, ηt) is the same as IF
RCT−EDR
1t (O;µ1t, ρt, α, γ, ηt) ex-
cept that the expectations are replaced by empirical averages.
Simple robust estimator of µ∗1t (RCT-SR)
When we examine the RCT-EDR estimating function (2.7), we notice that the
first part is itself an influence function









{µ∗t (X)− µ∗1t} , (2.9)
This influence function takes the form of an augmented inverse probability
weighted estimating function and is, according to the theory in Tsiatis (2006),
the most efficient influence function under assumption (A2) with only RCT data.
In addition, the influence function (2.9) has the following robustness property:
E
[
φRCT−SR1t {O;µ∗1t, ρ∗t , α∗1, f(X)}
]
= 0,
whatever be the choice of the function f(·) (i.e. regardless of whether µ∗t (X)
is modeled correctly). Therefore, we call (2.9) the simple robust (SR) influence
function. We use (2.9) as a benchmark by which to gauge the efficiency of the
“enriched” estimators of µ∗1t.
As for estimation, we estimate α∗1 from model Mπ as the solution α̂1 to
En [Sα1(T,R,X;α1)] = 0,
where
Sα1(T,R,X;α1) = R {T − π1(1;α1)} .
24
In keeping with the “simple” aspect of this estimator, we estimate η∗t using
data from the RCT only. Specifically, we can estimate η∗t using the estimating
function
RI{T = t}Sηt(Y,X; ηt)
This estimating function has mean zero at η∗t since assumptions (A1) – (A3)
imply that
(R, T )⊥ (Y1, Y0)|X.
Thus, we estimate η∗t as the solution η̂
S
t to
En [RI{T = t}Sηt(Y,X; ηt)] = 0.




φRCT−SR1t {O;µ1t, ρ̂t, α̂1, µt(X; η̂St )}
]
= 0,
where ρ̂t was defined previously.
Regardless of whether the working model for µ∗t (X) is correctly specified,








= φRCT-SR1t {O;µ∗1t, ρ∗t , α∗1, µt(X; η̃t)}
− E
[














Note that the second term on the right hand side of equation (2.10) van-
ishes when η̃t = η
∗





















1t (O;µ1t, ρt, α1, ηt) is the
same as IFRCT−SR1t (O;µ1t, ρt, α1, ηt) except that the expectations are replaced by
empirical averages.




The most efficient influence functions for estimating µ∗t and µ
∗
1t under the semi-
parametric model Pπ were presented, respectively, in (2.5) and (2.7) above.
Consistency of the associated estimators, µ̂CC−LEDRt and µ̂
RCT−EDR
1t , requires
correct specification of models for πt(0, X;α
∗
0) and λ(X; γ
∗), when the model
for µ∗t (X) is incorrectly specified.
It is natural to ask whether efficiency can be improved by further impos-
ing modeling restriction Mλ on the observed data. That is, we consider the
semiparametric model Pπλ which imposes restrictions on the distribution of the
observed data through assumptions (A1) – (A3) and the joint model (Mπ ∩
Mλ). Let T Oπλ denote the corresponding semiparametric tangent space. As
discussed above, the most efficient influence function for a given parameter of
interest is the projection (of the influence function of any RAL estimator of the
parameter) onto T Oπλ. In Appendix II, we show
T O,⊥πλ = T
O,⊥
π ⊕ Λc,
where T O,⊥π is defined as in (2.4) with λ













To derive the most efficient influence functions for estimating µ∗t and µ
∗
1t, we
can project the influence functions for the CC-IPW and RCT-SIPW estimators
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onto T Oπλ, respectively.






∣∣Λc] = 0. Thus, the most effi-
cient influence function for estimating µ∗t under Pπλ is equal to
φCC−LEDRt {O;µ∗t , α∗, λ∗(X), µ∗t (X)}. Therefore, as mentioned in Section 2.3.2,
the CC-LEDR estimator µ̂CC−LEDRt will be the locally efficient estimator of µ
∗
t
under the restrictions of assumption (A1) – (A3) and the joint model (Mπ ∩









∣∣Λc] 6= 0. The most efficient influence
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function for estimating µ∗1t under Pπλ is the projection
















































∣∣T Oπ ]− Π[URCT−SIPW1t (O;µ∗1t, ρ∗t )∣∣Λc]






















− I{T = t}(1−R)
πt(0, X;α∗0) {1− λ(X; γ∗)}
}{










πt(0, X;α∗0) {1− λ(X; γ∗)}
}−1






























We call (2.11) the locally efficient (LE) influence function for estimating µ∗1t,
which has mean 0 when evaluated at the truth {µ∗1t, ρ∗t , λ∗, α∗, γ∗, µ∗t (X)}. As
for estimation, we still employ the parametric model µ∗t (X) = µt(X; η
∗
t ) and the
corresponding estimator η̂t. Moreover, note that λ
∗ = P [R = 1] can be directly
estimated by the empirical average
λ̂ := En [I{R = 1}] .
Then we define µ̂RCT−LE1t as the solution to
En
[
φRCT−LE1t {O;µ1t, ρ̂t, λ̂, α̂, γ̂, µt(X; η̂t)}
]
= 0,
with the other estimators ρ̂t, α̂, γ̂ defined previously.
It is important to notice that the influence function (2.11) is robust to mis-
specification of the model for µ∗t (X) since
E
[
φRCT−LE1t {O;µ∗1t, ρ∗t , λ∗, α∗, γ∗, f(X)}
]
= 0,
whatever be the choice of the function f(·). In other words, the resulting es-
timator will be consistent as long as the joint model (Mπ ∩ Mλ) is correctly
specified; and if the working model for µ∗t (X) is correct as well, the resulting
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estimator will be asymptotically efficient. As a result, under the correct speci-






∗, α∗, γ∗, η̃t)
= φRCT−LE1t {O;µ∗1t, ρ∗t , λ∗, α∗, γ∗, µt(X; η̃t)}
− E
[
























where the last two terms on the right hand side of the equation vanish if η̃t = η
∗
t
(model for µ∗t (X) is correct). We hereby obtain the “partially robust” asymp-







∗, α∗, γ∗, η̃t)
2],
since it is robust to misspecification of the model for µ∗t (X) but still relies





1t , ρ̂t, λ̂, α̂, γ̂, η̃t)
2], where ÎF
RCT−LE
1t (O;µ1t, ρt, λ, α, γ, ηt)
is the same as IFRCT−LE1t (O;µ1t, ρt, λ, α, γ, ηt) except that the expectations are
replaced by empirical averages.
2.4 Simulation study
We present a simulation study to evaluate the finite sample performance of the
six proposed estimators, i.e. CC-IPW and CC-LEDR for µ∗t and RCT-SIW,
RCT-SR, RCT-EDR and RCT-LE for µ∗1t. We also assess the robustness of our
proposed estimation procedures by comparing the results under various types
of model misspecification.
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In this simulation, we generated 2000 datasets, each with a sample size
n = 500. We considered the following true data generating mechanism:
• X = (X1, X2)′, X1 ∼ Bernoulli(0.5), X2 ∼ N (0, 1) with X1 independent
of X2
• Given X, the random variables R, Y1 and Y0 were assumed to be indepen-
dent Bernoulli distributed with probabilities
P [R = 1|X] = expit(−0.5 +X1 −X2)
P [Y1 = 1|X] = expit(−0.5 +X1 +X2)
P [Y0 = 1|X] = expit(−1 +X1 + 1.5X2),
respectively.
• Given R,X, Y1, Y0, the random variable T was assumed to be Bernoulli
{π∗1(R,X)}, where
π∗1(R,X) = R · 0.5 + (1−R) · expit(X1 +X2).
• Set Y = TY1 + (1− T )Y0.
Under these assumptions, λ∗ = 0.5, P [T = 1|R = 1] = 0.5, P [T = 1|R = 0] =
0.65 and
µ∗1 = 0.5, µ
∗
0 = 0.4147, ∆CC = 0.0853;
µ∗11 = 0.4415, µ
∗
10 = 0.3311, ∆RCT = 0.1104.
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In our simulations, we report average bias, average of standard error esti-
mate, Monte Carlo standard deviation of the estimator, coverage of 95% Wald
confidence intervals, Monte Carlo mean squared error of the estimator, and the
relative efficiency with respect to the inverse probability weighted estimator.
The relative efficiency (RE) was computed as the ratio of the mean squared
errors (MSEs) between the CC-IPW (or RCT-SIPW) estimator and the esti-
mator of interest for the same parameter. When applicable, we used estimates
of asymptotic variances that are robust to model misspecification.
Table 2.2 shows that all estimators are unbiased under correct model spec-
ifications, for given sample size (n = 500). Moreover, the average of standard
error estimates agrees well with the Monte Carlo standard deviation of the pa-
rameter estimators, and the coverage of the estimated 95% confidence intervals
is close to their nominal level. As for the efficiency comparison, we observe from
the MSE and RE columns that
• the CC-LEDR estimator is more efficient than the CC-IPW estimator
• the RCT-SR estimator improves the efficiency compared to the RCT-
SIPW estimator
• the RCT-EDR and RCT-LE estimators yield large efficiency gains com-
pared to the RCT-SIPW estimator – doubling the efficiency for estimating
∆RCT , which is equivalent (asymptotically) to a 50% reduction in the sam-
ple size required to achieve a desired power
• the advantage of the RCT-LE estimator over the RCT- EDR estimator is
minimal.
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In Table 2.3, we present results when the model for µ∗t (X) is misspecified.
Specifically, we incorrectly dropped the continuous componentX2 from the mod-
els for both µ∗1(X) and µ
∗
0(X). The two inverse probability weighted estimators,
CC-IPW and CC-SIPW, are unchanged since they do not utilize estimators of
µ∗t (X). As expected, all the estimators are unbiased with some loss in efficiency
as compared to the results shown in Table 2.2. The average of estimated stan-
dard errors agrees well with the Monte Carlo standard deviations. The coverage
rates of the 95% confidence intervals are roughly accurate, which implies good
performance of our robust variance estimators (when applicable). In addition,
the summary statistics for the RCT-EDR and RCT-LE estimators are nearly
identical in Table 2.3 (any differences are due to differences in the computation
of the standard error estimator). This is due to the fact that the RCT-LE esti-
mator reduces to the RCT-EDR estimator when the working model for µ∗(X)
involves only a binary covariate that is shared with model Mλ. In this case,
the empirical average of the last term in the RCT-LE estimating function (2.11)
can be shown to equal zero, with γ̂ plugged in for γ∗.
In Table 2.4, we consider the case where the joint model (Mπ ∩ Mλ) is
misspecified. We incorrectly dropped the continuous component X2 from mod-
els Mπ and Mλ. Compared to the results under correct model specification
in Table 2.2, only the RCT-SIPW and RCT-SR estimators remain exactly un-
changed since they don’t utilize π∗t (0, X) or λ
∗(X). As expected, the CC-LEDR,
RCT-SIPW, RCT-SR and RCT-EDR estimators are consistent, with proper
coverage of the 95% confidence intervals. Interestingly, RCT-EDR maintains
its advantage in terms of efficiency over RCT-SIPW and RCT-SR under model
misspecification, despite the fact that this is not guaranteed by theory. This
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finding may simply be an artifact of our particular simulation study.
Table 2.2: Finite sample properties comparison under correct model
specifications




µ∗1 CC-IPW 0.0005 0.0300 0.0303 95.0 0.0009 1.000
CC-LEDR 0.0003 0.0286 0.0290 94.6 0.0008 1.088
µ∗0 CC-IPW 0.0009 0.0380 0.0399 93.6 0.0016 1.000
CC-LEDR 0.0012 0.0319 0.0317 95.2 0.0010 1.584
∆CC CC-IPW -0.0004 0.0466 0.0484 94.0 0.0023 1.000
CC-LEDR -0.0009 0.0400 0.0404 94.6 0.0016 1.433
µ∗11 RCT-SIPW 0.0003 0.0443 0.0437 94.9 0.0019 1.000
RCT-SR 0.0003 0.0420 0.0415 95.0 0.0017 1.104
RCT-EDR 0.0001 0.0333 0.0336 95.0 0.0011 1.686
RCT-LE 0.0001 0.0333 0.0336 94.6 0.0011 1.687
µ∗10 RCT-SIPW 0.0009 0.0421 0.0412 95.7 0.0017 1.000
RCT-SR 0.0008 0.0389 0.0381 95.5 0.0015 1.167
RCT-EDR 0.0012 0.0328 0.0323 94.8 0.0010 1.629
RCT-LE 0.0013 0.0326 0.0322 94.8 0.0010 1.633
∆RCT RCT-SIPW -0.0006 0.0612 0.0598 95.0 0.0036 1.000
RCT-SR -0.0006 0.0534 0.0524 95.3 0.0027 1.302
RCT-EDR -0.0011 0.0420 0.0417 95.0 0.0017 2.051
RCT-LE -0.0012 0.0418 0.0417 95.0 0.0017 2.056
† RE: relative efficiency with respect to the CC-IPW or RCT-SIPW estimator for the same
parameter, computed as ratio of MSEs
2.5 Analysis of BARI
BARI (Bypass Angioplasty Revascularization Investigation) was designed to
compare survival in patients receiving either percutaneous transluminal coro-
nary angioplasty (PTCA) or coronary artery bypass grafting (CABG). As sum-
marized in Brooks et al. (2000), a comprehensive cohort design was adopted to
include 3,839 patients who were clinically eligible with severe angina or ischemia
and multivessel coronary artery disease suitable for initial revascularization by
either PTCA or CABG, and willing to be followed up. Among these patients,
1,829 patients consented to randomization and entered a randomized trial. The
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Table 2.3: Finite sample properties comparison when µ∗t (X) is misspecified




µ∗1 CC-IPW 0.0005 0.0300 0.0303 95.0 0.0009 1.000
CC-LEDR 0.0005 0.0293 0.0296 95.0 0.0009 1.045
µ∗0 CC-IPW 0.0009 0.0380 0.0399 93.6 0.0016 1.000
CC-LEDR 0.0009 0.0356 0.0359 94.3 0.0013 1.233
∆CC CC-IPW -0.0004 0.0466 0.0484 94.0 0.0023 1.000
CC-LEDR -0.0004 0.0448 0.0456 94.8 0.0021 1.125
µ∗11 RCT-SIPW 0.0003 0.0443 0.0437 94.9 0.0019 1.000
RCT-SR 0.0002 0.0436 0.0429 95.1 0.0018 1.034
RCT-EDR 0.0006 0.0345 0.0348 94.6 0.0012 1.577
RCT-LE 0.0006 0.0345 0.0348 94.8 0.0012 1.577
µ∗10 RCT-SIPW 0.0009 0.0421 0.0412 95.7 0.0017 1.000
RCT-SR 0.0010 0.0416 0.0409 95.7 0.0017 1.012
RCT-EDR 0.0013 0.0345 0.0344 94.6 0.0012 1.434
RCT-LE 0.0013 0.0345 0.0344 94.5 0.0012 1.434
∆RCT RCT-SIPW -0.0006 0.0612 0.0598 95.0 0.0036 1.000
RCT-SR -0.0008 0.0595 0.0585 95.8 0.0034 1.045
RCT-EDR -0.0007 0.0463 0.0465 94.6 0.0022 1.653
RCT-LE -0.0007 0.0463 0.0465 94.5 0.0022 1.653
† RE: relative efficiency with respect to the CC-IPW or RCT-SIPW estimator for the same
parameter, computed as ratio of MSEs
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Table 2.4: Finite sample properties comparison
when the joint model (Mπ ∩ Mλ) is misspecified




µ∗1 CC-IPW 0.0261 0.0296 0.0300 85.7 0.0016 1.000
CC-LEDR 0.0003 0.0285 0.0290 94.6 0.0008 1.879
µ∗0 CC-IPW -0.0628 0.0346 0.0348 56.4 0.0051 1.000
CC-LEDR 0.0011 0.0316 0.0314 95.2 0.0010 5.217
∆CC CC-IPW 0.0889 0.0453 0.0460 51.0 0.0100 1.000
CC-LEDR -0.0008 0.0398 0.0402 94.8 0.0016 6.207
µ∗11 RCT-SIPW 0.0003 0.0443 0.0437 94.9 0.0019 1.000
RCT-SR 0.0003 0.0420 0.0415 95.0 0.0017 1.104
RCT-EDR 0.0001 0.0332 0.0334 95.0 0.0011 1.705
RCT-LE 0.0795 0.0287 0.0297 22.0 0.0072 0.265
µ∗10 RCT-SIPW 0.0009 0.0421 0.0412 95.7 0.0017 1.000
RCT-SR 0.0008 0.0389 0.0381 95.5 0.0015 1.167
RCT-EDR 0.0013 0.0327 0.0322 94.7 0.0010 1.630
RCT-LE 0.1020 0.0324 0.0325 11.8 0.0115 0.148
∆RCT RCT-SIPW -0.0006 0.0612 0.0598 95.0 0.0036 1.000
RCT-SR -0.0006 0.0534 0.0524 95.3 0.0027 1.302
RCT-EDR -0.0011 0.0419 0.0416 95.4 0.0017 2.066
RCT-LE -0.0226 0.0397 0.0408 91.1 0.0022 1.641
† RE: relative efficiency with respect to the CC-IPW or RCT-SIW estimator for the same
parameter, computed as ratio of MSEs
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remaining 2,010 patients refused randomization but agreed to participate in the
BARI registry, in which patients could choose their initial treatment in con-
sultation with their physician. The follow-up plan was similar for randomized
(RCT) and registry (OBS) patients.
In the OBS, “treatment” was defined as the first revascularization treatment
received in the 3-month interval after study entry. One hundred and ninety-size
registry patients did not receive any revascularization procedure during the 3-
month interval and were excluded from the analysis. Also excluded were 33 RCT
patients who did not receive their assigned treatment. While these exclusions
are a strict departure from the intention-to-treat principle, they are commonly
employed in treatment trials (often called modified intention-to-treat). Thus, a
total of 3,610 patients were considered for inclusion in our analysis (1,814 from
OBS and 1,796 from RCT). Among RCT patients, 904 (50.3%) were random-
ized to receive PTCA. Among OBS patients, 1,189 (65.5%) chose and received
PTCA. These proportions are comparable to what we used in our simulation
study.
The BARI Investigators (1996) reported 5-year mortality results for the RCT
and compared the treatment groups using the logrank test. Feit et al. (2000) re-
ported 7-year mortality results for the OBS and used Cox proportional hazards
regression to computed adjusted (for baseline risk factors) differences between
treatment groups. Neither paper found a statistically significant difference be-
tween PTCA and CABG in terms of mortality. For approximately 650 patients
with treated diabetes, Detre et al. (1999) estimated unadjusted treatment ef-
fects among RCT patients and adjusted treatment effects (using multivariable
Cox proportional hazards regression) among OBS patients. For RCT patients
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(173 CABG, 170 PTCA), they found a significant increased risk of mortality
for PTCA vs. CABG. For OBS patients (117 CABG, 182 PTCA), there was an
increased risk but not statistically significant. Focusing on 5-year all-cause and
cardiac mortality among all eligible and enrolled patients, Brooks et al. (2000)
combined the RCT and OBS data to build a multivariable Cox proportional
hazards regression model using randomization consent status, treatment group,
baseline risk factors and two-way interactions. Their main goal was to identify
risk factors for mortality as well as identify subgroup effects. They found that
diabetic patients receiving insulin were at significantly increased risk for both
all-cause and cardiac mortality if treated with PTCA vs. CABG. Further, pa-
tients with ST elevation were at increased risk of of cardiac mortality if treated
with CABG vs. PTCA.
In our re-analysis, we aim to estimate the comprehensive cohort and the ran-
domized trial causal effects of initial PTCA versus CABG treatment on 5-year
mortality. The word “initial” is used to emphasize the first revascularization
treatment (PTCA vs. CABG) received, as subsequent revascularization pro-
cedures (possibly different from the first treatment) actually occurred in some
patients. Four censored patients had follow-up time less than 5 years and were
excluded from our analysis.
In our analysis, R denotes the randomization consent indicator, T denotes
the indicator of receiving PTCA, Y denotes the binary indicator of death by the
end of 5 years and X is a vector of 17 baseline variables, including age, gender,
race, highest level of education, number of diseased vessels, category of quali-
fying symptoms, levels of self reported health, systolic blood pressure, diastolic
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blood pressure, and a set of indicators for proximal left anterior descending dis-
ease, prior myocardial infarction, heart failure, history of diabetes, history of
treated diabetes, current smoking, hypertension, and renal dysfunction. Other
baseline covariates with missingness greater than 10% for the whole study pop-
ulation were dropped from our analysis. For illustrative purposes only, subjects
with missingness in any of the 17 baseline covariates were excluded, resulting in
an analysis of 3,279 patients (90.8% of the sample after the initial exclusions),
among which 1,518 were from OBS and 1,761 from RCT.
We fit logistic regression models for λ∗(X) and π∗t (0, X). For the CC-LEDR,
RCT-EDR and RCT-LE estimators, logistic regression models were fit for µ∗1(X)
and µ∗0(X) based on all the data. For the RCT-SR estimator, these latter models
were fit for µ∗1(X) and µ
∗
0(X) based only on the RCT data. For all the models,
an intercept and main effect terms for X were included.
Table 2.5 displays the estimated comprehensive cohort and randomized trial
causal effects for the different estimation procedures. In addition to the point
estimates and associated standard errors (SE), we also report 95% Wald-based
confidence intervals (CI), two-sided p-values, and the relative efficiency (RE)
with respect to the inverse probability weighted estimator of the same parame-
ter. Here, RE is defined as the ratio of the estimated variance (squared standard
error) between the CC-IPW (or RCT-SIPW) estimator and the estimator of in-
terest for the same parameter.
For the comprehensive cohort causal effect, the CC-LEDR estimator is closer
to the null and slightly more efficient than the CC-IPW estimator. Neither
approach indicates a statistically significant difference between treatment groups
with respect to five-year mortality for the entire cohort. For the randomized trial
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causal effect, the RCT-EDR and RCT-LE is much closer to the null and much
more efficient than the RCT-SIPW and RCT-SR estimators. In fact, inference
based on the simple estimators are of borderline statistically significant, while
those based on the enriched estimators are not. These results confirm that
there are no statistically significant differences between treatment groups with
respect to five-year mortality for the RCT cohort. Interestingly, the efficient
comprehensive cohort (CC-LEDR) and randomized causal effect (RCT-EDR,
RCT-LE) estimates are virtually identical, whereas the inefficient estimators
were more disparate. In sum, our findings are consistent with the findings of
the BARI Investigators (1996) and Feit et al. (2000).
Table 2.5: Comprehensive cohort and randomized trial causal effect of






SE 95% CI P-value RE†
PTCA CC-IPW 11.0 0.7 (9.5, 12.4) <0.001 1.000
(comprehensive) CC-LEDR 10.8 0.7 (9.4, 12.2) <0.001 1.087
CABG CC-IPW 9.1 0.8 (7.6, 10.6) <0.001 1.000
(comprehensive) CC-LEDR 9.4 0.8 (8.0, 10.9) <0.001 1.031
PTCA-CABG CC-IPW 1.9 1.1 (-0.2, 4.0) 0.074 1.000
(comprehensive) CC-LEDR 1.4 1.0 (-0.6, 3.3) 0.182 1.100
PTCA RCT-SIPW 13.3 1.1 (11.1, 15.5) <0.001 1.000
(randomized) RCT-SR 13.1 1.1 (11.0, 15.3) <0.001 1.098
RCT-EDR 11.5 0.8 (10.0, 13.1) <0.001 2.071
RCT-LE 11.5 0.8 (10.0, 13.0) <0.001 2.099
CABG RCT-SIPW 10.3 1.0 (8.3, 12.3) <0.001 1.000
(randomized) RCT-SR 10.4 1.0 (8.4, 12.3) <0.001 1.060
RCT-EDR 10.1 0.8 (8.5, 11.8) <0.001 1.556
RCT-LE 10.2 0.8 (8.6, 11.8) <0.001 1.571
PTCA-CABG RCT-SIPW 3.0 1.5 (-0.0, 6.0) 0.050 1.000
(randomized) RCT-SR 2.7 1.4 (-0.0, 5.5) 0.054 1.159
RCT-EDR 1.4 1.1 (-0.8, 3.5) 0.205 1.988
RCT-LE 1.3 1.1 (-0.8, 3.4) 0.226 2.004
† RE: relative efficiency with respect to the CC-IPW or RCT-SIPW estimator for
the same parameter, computed as ratio of squared SEs.
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2.6 Conclusion and Discussion
In this paper, we introduced new procedures for estimating causal effects of a bi-
nary treatment in the comprehensive cohort study (CCS) design. We introduced
two estimators of the comprehensive cohort causal effect and four estimators for
the randomized trial causal effect. Based on our simulation and data analysis, we
recommend the CC-LEDR estimator for the comprehensive cohort causal effect,
and the RCT-EDR estimator for the randomized trial causal effect. These esti-
mators have improved efficiency relative to their inverse probability weighting
counterparts and they offer robustness to model mis-specification. The RCT-SR
estimator does provide efficiency and robustness over the RCT-SIPW estimator,
but by using only RCT data it cannot compete with the RCT-EDR estimator.
Compared to the RCT-EDR estimator, the advantage of the RCT-LE estimator
in terms of efficiency appears limited, and it does not offer advantages in terms
of robustness.
In specific regards to estimation of the randomized trial causal effect, there
are important open questions that require further exploration. While it appears
in our simulation study and data analysis that use of the RCT-EDR estimator
results in a precision gain (relative to the RCT-SIPW estimator) comparable
to the increase in observations from the OBS, this is not necessarily the case.
In fact, there is no theoretical guarantee that the RCT-EDR will be be more
precise than RCT-SIPW, in the presence of model misspecification. In future
work, it will be useful to explore whether the ideas of Tan (2006), Tan (2010)
and Rotnitzky et al. (2012) can be used to create an enriched doubly robust
estimator that is guaranteed to be more efficient than RCT-SIPW. In addition,
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it will be useful to develop a method for designing CCS’s that properly balance
statistical efficiency and logistics. We also note that Colantuoni and Rosenblum
(2015) have proposed methods for leveraging prognostic baseline variables in
randomized trials to construct more efficient estimators than RCT-SIPW. In
future work, it will be useful to compare the RCT-EDR estimator to their
estimator and see if it is possible to build an enriched doubly robust estimator
that is guaranteed to have better efficiency properties.
Finally, for both estimands, the methods in this paper need to be extended
to deal with time-to-event endpoints and missing data, both for outcomes and
covariates.
2.7 Appendices
2.7.1 Appendix I: The space T O,⊥π
To clarify the data structure, we first define the full data F and the complete
data L as:
F := (X ′, Y1, Y0)
′
L := (X ′, Y1, Y0, R, T )
′
We rewrite the observed data O in terms of the potential outcomes as:
O = (X ′, TY1, (1− T )Y0, R, T )′ .
To study the semi-parametric tangent space for the observed data, we start
with the restrictions on the complete data. Given assumptions (A1) – (A3), the
likelihood of the complete data takes the form
f(X, Y1, Y0) · P (R|X) · P (T |R = 1)R · P (T |R = 0, X)1−R.
42
Under the additional model restrictionMπ, we can express the semi-parametric
tangent space for the complete data as:
T Lπ = T
F ⊕T R|X ⊕T T |R,Xπ ,
where
T F = {a(X, Y1, Y0) : E [a(X, Y1, Y0)] = 0}
T R|X = {a(X) {R− λ∗(X)} : for any a(X)}





{T − π1(R,X;α∗)} : for all k
}
Using Tsiatis (2006), the corresponding semi-parametric tangent space for
the observed data can be shown to be








T O,⊥π = T F,⊥ ∩T {R|X},⊥ ∩T {T |R,X},⊥π .
It can be shown that
T F,⊥ =
{
h(O) : E [h(O)|F ]⊥T F , E[h(O)] = 0
}















− I{T = τ}(1−R)
πτ (0, X;α∗0) {1− λ∗(X)}
}
hτ (X, Yτ )
φ3{O;α∗0, λ∗(X), b} =
1−R
1− λ∗(X)





Moreover, in order for any h(O) ∈ T F,⊥ to be orthogonal to T R|X and T T |R,Xπ ,
h0, h1, b must satisfy the following conditions:












1)h1(X, Y1)− π1(1;α∗1)h0(X, Y0)] = 0,
which are jointly equivalent to







{b(X) + E [h0(X, Y0)|X]}
]
= 0
E [h1(X, Y1)] = E [h0(X, Y0)] = 0
Writing hτ (X, Yτ ) = {hτ (X, Yτ )− E [hτ (X, Yτ )|X]}+E [hτ (X, Yτ )|X], we can
express the orthogonal complement of the semi-parametric tangent space as
T O,⊥π = Λh ⊕ Λb ⊕ Λa,
44
where
Λh = Λh0 ⊕ Λh1
Λhτ = {φ2τ{O;α∗, λ∗(X), hτ} : E [hτ (X, Yτ )|X] = 0} τ = 0, 1.
Λb =
{










Λa = {φ4{O;α∗1, λ∗(X), a} : E [a(X)] = 0}
for










It is important to note that Λh0 ,Λh1 ,Λb,Λa are pairwise orthogonal to each
other.
2.7.2 Appendix II: The space T O,⊥πλ
Continuing with the results in Appendix I, we derive the orthogonal comple-
ment of the semiparametric tangent space that imposes the additional model
restriction Mλ, i.e., T O,⊥πλ . Under Mλ,
λ∗(X) = λ(X; γ∗) =
exp {q(X; γ∗)}
1 + exp {q(X; γ∗)}
, (2.13)










T O,⊥πλ = T




In order for any h(O) ∈ T F,⊥ to be orthogonal to T R|Xλ and T
T |R,X
π , h0, h1, b



















1)h1(X, Y1)− π1(1;α∗1)h0(X, Y0)] = 0
Writing
hτ (X, Yτ ) = hτ (X, Yτ )− E [hτ (X, Yτ )|X] + E [hτ (X, Yτ )|X]
− π1−τ (R,X;α∗)E [hτ (X, Yτ )|X] + πτ (R,X;α∗)E [h1−τ (X, Y1−τ )|X]
+ π1−τ (R,X;α
∗)E [hτ (X, Yτ )|X]− πτ (R,X;α∗)E [h1−τ (X, Y1−τ )|X]
= {hτ (X, Yτ )− E [hτ (X, Yτ )|X]}
+ πτ (R,X;α
∗)E [h0(X, Y0) + h1(X, Y1)|X]
+ {π1−τ (R,X;α∗)E [hτ (X, Yτ )|X]− πτ (R,X;α∗)E [h1−τ (X, Y1−τ )|X]} ,
we can express the orthogonal complement of the semi-parametric tangent space
as
T O,⊥πλ = Λh ⊕ Λb ⊕ Λa ⊕ Λc,


















λ(X; γ∗) {1− λ(X; γ∗)}
}
c(X)
Again, note that Λh0 ,Λh1 ,Λb,Λa,Λc are pairwise orthogonal to each other.
2.7.3 Appendix III: Projections
We list here the projections of an arbitrary function of the observed data (with
mean zero and finite variance) onto Λhτ (τ = 0, 1),Λb,Λa and Λc, respectively.
LetHO denote the observed data Hilbert space of all one dimensional, mean-
zero measurable functions of O with finite variance, equipped with the covari-
ance inner product.






− I{T = τ}(1−R)









πτ (0, X;α∗0) {1− λ∗(X)}
}−1
× {Ch(X, Yτ )− E [Ch(X, Yτ )|X]} ,
where







− I{T = τ}(1−R)
πτ (0, X;α∗0) {1− λ∗(X)}
}∣∣∣∣X, Yτ]
for τ = 0, 1.





















































































































































When drawing inference about treatment effects in observational studies, it is
important to adjust for potential confounding variables. Thus, it is important
that these variables be collected. Unfortunately, certain variables, e.g., informa-
tion from medical records, may be expensive to collect and, due to budgetary
restrictions, cannot be ascertained on all subjects in the study sample. To ad-
dress this issue, the outcome-dependent two-phase sampling design has been
proposed (see, for example, White (1982) for case-control studies).
In the first phase, a simple random sample is drawn from the source popula-
tion, with information obtained from all subjects in the study on treatment T ,
outcome Y and covariates S which are inexpensive to measure. In the second
phase, subjects are classified into strata according to (S, Y, T ) and a random
subsample, called a validation sample, is drawn from each stratum with stratum-
specific sampling probabilities. Covariates W (expensive to obtain) are mea-
sured on subjects in the validation sample. The two-phase sampling design was
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first introduced by Neyman (1938) and discussed in Cochran (1963) (referred
to as double sampling for stratification). With well-defined strata and wisely-
chosen stratum-specific sampling probabilities, such designs can yield efficient
parameter estimates given constraints on the validation sample size.
The issue of how to choose the strata to maximize the efficiency of the design
has a long history, starting with Neyman (1934). The issue is complicated even
when the stratification is based on a single univariate continuous variable (see,
for example, Baillargeon and Rivest (2009)).
In this paper, we are interested in the optimal sampling scheme once the
strata have been determined. Breslow and Cain (1988) and Breslow and Chat-
terjee (1999) have argued for a “balanced” design in which approximately equal
numbers per stratum are selected at the second phase. Our idea is motivated by
Reilly and Pepe (1995) and Gilbert et al. (2014), where the optimal sampling
scheme within stratum for fixed (expected) phase two sample size or budget was
determined by minimizing the asymptotic variance of a given estimator.
Given the strata, the optimal choice of the stratum-specific sampling proba-
bilities depends on the exact statistical procedure used, specifically, the estima-
tor for the parameter of interest. As pointed out in Wang et al. (2009), previous
statistical methods for outcome-dependent two-phase sampling studies mainly
focused on consistent and efficient estimators for the regression parameters of
the distribution of the observed outcome Y given treatment T and covariates
S,W ; examples include Cosslett (1981, 1983), White (1982), Fears and Brown
(1986), Breslow and Cain (1988), Carroll and Wand (1991), Pepe and Fleming
(1991), Scott and Wild (1991, 1997), Schill et al. (1993), Robins et al. (1995),
Breslow and Holubkov (1997a,b), Lawless et al. (1999), Breslow (2000), Breslow
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et al. (2003), Chatterjee et al. (2003), Weaver and Zhou (2005), etc.
In this paper, we follow the methods developed in Wang et al. (2009) and
focus on the estimators of the causal effect of a binary treatment on an out-
come of interest; specifically, the difference in the marginal mean of the po-
tential outcomes under two competing treatments. To assess the asymptotic
variance of the estimators, we consider a class of influence functions considered
by Wang et al. (2009). We specifically focus on influence functions associated
with the simple inverse probability weighted and enriched doubly robust estima-
tors. Given data from the first phase, our goal is to find the best stratum-specific
sampling scheme that minimizes the variance of a given estimator, subject to
the constraint of the expected validation sample size.
The variance depends on the conditional distribution of the expense covari-
ates given first phase data. This variance cannot be estimated without second
phase data. To address this issue, we propose an intermediate step to collect
information on expensive covariates on a stratified sample of patients. We use
these intermediate data to estimate the variance we seek to minimize and com-
pute the optimal sampling probabilities that are used for determining the final
validation sample. This approach contrasts with the approach of Gilbert et al.
(2014), who propose to estimate the unknown conditional distribution using
subject matter knowledge and separate pilot data.
Intuitively, our optimization procedure will produce a sampling allocation
scheme similar in spirit to the Neyman allocation (Neyman, 1934), which sets
the sampling fraction per stratum proportional to the stratum-specific standard
deviation of outcomes, i.e. strata with larger variances are sampled more heavily
to reduce the variance of the corresponding stratum mean. In our algorithm,
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the “stratum-specific standard deviation” refers to a similar stratum-specific
quantity that involves only the relevant expression identified from the influence
function of the resulting estimator. Since our optimization procedure involves
stricter constraints than the Neyman allocation procedure, no closed-form ana-
lytical solution is provided. Instead, the optimal stratum-specific sampling prob-
abilities can be determined numerically using off-the-shelf optimization software.
The paper is organized as follows. In Section 3.2 we introduce our method-
ology. Specifically, we introduce the notation and data structure, review the
estimation procedures of Wang et al. (2009), extend their procedures to al-
low for estimated, rather than known, sampling probabilities, and discuss the
optimization algorithm for identifying the optimal sampling scheme. For sim-
plicity of the formulae, Section 3.2 focuses on inference about the mean of the
potential outcome under a single treatment, not the causal effect of interest.
However, the ideas naturally generalize. In Section 3.3, we present results of a
simulation study. In Section 3.4, we illustrate our methods using data from an
observational study of critically ill patients in which some patients were treated
with right heart catheterization (RHC). This dataset has been used previously
to demonstrate methods for estimating the causal effect of RHC on 30-day sur-
vival. We use these data to build and evaluate hypothetical two-phase sampling
designs based on different casual effect estimation procedures. The final section
is devoted to a discussion.
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3.2 Methods
Using the notation and framework in Wang et al. (2009), assume that we observe
n independent and identically distributed copies of O = (S ′, Y, T, V, V W ′)′,
where S is the vector of inexpensive covariates, Y the outcome, T the treatment
indicator, V the validation indicator and W is the vector of expensive covariates.
Note that (S ′, Y, T )′ is collected on all n subjects in the first phase, based on
which a validation sample is randomly drawn in the second phase; and the
expensive covariates W are measured only on the validation sample. For the
validation sample, suppose that we aim to select no more than n1 subjects
among the treated (T = 1) and n0 among the untreated (T = 0).
According to the study design, we denote q(S, Y, T ) = P [V = 1|S, Y, T ],
i.e. the probability of being selected as part of the validation sample. Define
qt(S, Y ) = q(S, Y, t), t = 0, 1. The degrees of freedom of q(S, Y, T ) depends on
the dimension of the first phase data. When it is high-dimensional, we will use
dimension reduction/categorization procedures to classify subjects into a limited
number (K) of strata. Let r : (S, Y, T ) 7→ {1, . . . , K} be the stratification func-
tion. For all subjects in stratum k (i.e., r(S, Y, T ) = k), we assume the probabil-
ity of being selected into the validation sample is qk := P [V = 1|r(S, Y, T ) = k].
So, q(S, Y, T ) =
∑K
k=1 qkI{r(S,Y,T )=k}.
Let Y1 and Y0 be the potential outcomes for treatment 1 and 0 respectively.
We make the “stable unit treatment value” assumption (Rubin (1986)) and
consistency assumption (i.e., Y = TY1 + (1 − T )Y0). The target parameter of
interest is µ∗t = E[Yt]. To identify µ
∗
t from the observed data, we assume that
T is independent of (Y1, Y0) given the complete set of covariates X = (S
′,W ′)′.
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We denote the treatment assignment probability by π∗t (X) = P [T = t|X] and




3.2.1 Estimators of µ∗t
Wang et al. (2009) developed regular and asymptotically linear (RAL) esti-
mators of µ∗t which depend on known q(S, Y, T ). The class of estimators con-
sidered by Wang et al. (2009) require specification of parametric models for
π∗t (X) = πt(X;α
∗) (treatment regression model) and µ∗t (X) = µt(X; η
∗) (out-
come regression model), where α∗ and η∗ denote the true value of model pa-
rameters α and η, respectively. The influence functions for RAL estimators of
µ∗t take the form:
IFt (O;µ
∗
t , α̃, η̃) =
V
qT (S, Y )
h1t (X, Y, T ;µ
∗
t , α̃, η̃) + h2t (S, Y, T ;µ
∗
t , α̃, η̃) , (3.1)
where either α̃ = α∗ (the treatment regression model is correct) or η̃ = η∗ (the
outcome regression model is correct); and h1t(·), h2t(·) are specific functions not
involving q(S, Y, T ). The associated asymptotic variance for an estimator of µ∗t










q(S, Y, T )
E
[
h1t(X, Y, T ;µ
∗
t , α̃, η̃)
2








h1t(X, Y, T ;µ
∗
t , α̃, η̃)
2 r(S, Y, T ) = k
]
P [r(S, Y, T ) = k] + Ct
for some constant Ct that does not depend on q(S, Y, T ). Thus, minimizing the
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h1t(X, Y, T ;µ
∗
t , α̃, η̃)
2 r(S, Y, T ) = k
]
P [r(S, Y, T ) = k] (3.2)
over q1, . . . , qK .
We highlight two estimators: simple inverse probability weighted (SIPW)
estimator and enriched doubly robust (EDR) estimator.
SIPW estimator







which has mean 0 evaluated when at the truth µ∗t and π
∗
t (X). To estimate µ
∗
t
using this estimating function, Wang et al. (2009) posited a logistic regression
model for π∗t (X) of the form:





where l(X;α) is a specified function of X and α and α∗ is the true value of α.
Then (µ∗t , α





















Let (µ̂SIPWt , α̂) denote the solution to (3.3). As pointed out in Wang et al.









∗)− ASIPWt (µ∗t , α∗)
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It is useful to note that ASIPWt (µ
∗
t , α
∗) does not depend on q(S, Y, T ). Now, we













(Y − µ∗t )− ASIPWt (µ∗t , α∗)Sα(T,X;α∗)
}
which is exactly in the form of (3.1), with
h1t(X, Y, T ;µt, α, η) = h
SIPW




(Y − µt)− ASIPWt (µt, α)Sα(T,X;α) (3.4)
h2t(S, Y, T ;µt, α, η) = h
SIPW
2t (S, Y, T ;µt, α) = 0
EDR estimator
Wang et al. (2009) proposed and recommended the enriched doubly robust esti-
mator, which incorporates the information from the non-validation sample. In
simulation studies, they showed that the EDR estimator is more efficient and
robust to model misspecification than the SIPW estimator. In the construction
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of their EDR estimator, Wang et al. (2009) posited, in addition to the model for
π∗t (X), a model for µ
∗
t (X) = µt(X; η
∗), where η∗ denotes the true value of the
model parameter η. They introduced the following EDR estimating function:
UEDRt (O;µt, α, η) =
V
qT (S, Y )




qT (S, Y )
− 1
}
E [ϕt (X, Y, T ;µt, α, η)|S, Y, T ] ,
where








{µt(X; η)− µt} .







when either α̃ = α∗ (model for π∗t (X) is correctly specified) or η̃ = η
∗ (model
µ∗t (X) is correctly specified).
The parameters (µ∗t , α
∗, η∗) are estimated by solving
En




 = 0, (3.5)
where Stη(Y,X; η) is the corresponding score function for η from the model for
µ∗t (X), Û
EDR
t (O;µt, α, η) is the same as U
EDR
t (O;µt, α, η) except that
E [ϕt (X, Y, T ;µt, α, η)|S, Y, T ] is replaced by an estimator, e.g.,
K∑
k=1
I(r(S, Y, T ) = k)Ê
[
V
qT (S, Y )
ϕt (X, Y, T ;µt, α, η)
∣∣∣∣ r(S, Y, T ) = k] .
Let (µ̂EDRt , α̂, η̂) denote the solution to (3.5). In fact, when either α̃ = α
∗ or
η̃ = η∗, the estimator µ̂EDRt will be consistent and asymptotically normal even
if the estimator for E [ϕt (X, Y, T ;µt, α, η)|S, Y, T ] is biased.
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The influence function for µ̂EDRt can be shown to be
IFEDRt (O;µ
∗
t , α̃, η̃)
= UEDRt (O;µ
∗
t , α̃, η̃)− AEDRt (µ∗t , α̃, η̃)
V
qT (S, Y )
Sα(T,X; α̃)
− HEDRt (µ∗t , α̃, η̃)
V I{T=t}
qT (S, Y )
Stη(Y,X; η̃)
where either α̃ = α∗ or η̃ = η∗, and
AEDRt (µ
∗
















∂ϕt (X, Y, T ;µ
∗


























∂ϕt (X, Y, T ;µ
∗















t , α̃, η̃) do not depend upon q(S, Y, T ).
We can re-express IFEDRt (O;µ
∗
t , α̃, η̃) as
IFEDRt (O;µ
∗
t , α̃, η̃)
=
V
qT (S, Y )
{
ϕt (X, Y, T ;µ
∗
t , α̃, η̃)− E [ϕt (X, Y, T ;µ∗t , α̃, η̃)|S, Y, T ]
− AEDRt (µ∗t , α̃, η̃)Sα(T,X; α̃)− HEDRt (µ∗t , α̃, η̃)I{T=t}Stη(Y,X; η̃)
}
+ E [ϕt (X, Y, T ;µ
∗
t , α̃, η̃)|S, Y, T ] ,
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which is also in the form of (3.1), with
h1t(X, Y, T ;µt, α, η) = h
EDR
1t (X, Y, T ;µt, α, η)
= ϕt (X, Y, T ;µt, α, η)− E [ϕt (X, Y, T ;µt, α, η)|S, Y, T ]
− AEDRt (µt, α, η)Sα(T,X;α)− HEDRt (µt, α, η)I{T=t}Stη(Y,X; η)
(3.6)
h2t(S, Y, T ;µt, α, η) = h
EDR
2t (S, Y, T ;µt, α, η)
= E [ϕt (X, Y, T ;µt, α, η)|S, Y, T ]
Empirical estimation of q(S, Y, T )
The asymptotic variance of influence function (3.1) that was presented in (3.2)
was computed under the assumption that q(S, Y, T ) is known and not estimated
from the observed data. However, it can be shown that extra efficiency can
be gained by considering q(S, Y, T ) to be unknown and using estimates in the
solving (3.3) and (3.5) above.
Under our dimension reduction/categorization assumption, we know that
q(S, Y, T ) is determined by the qk’s, where qk = P [V = 1|r(S, T, Y ) = k]. As a
result, an unbiased estimating function for qk is
Uk(S, T, Y ; qk) = I{r(S,T,Y )=k}(V − qk)
and qk can be estimated as the solution q̂k to
En[Uk(S, T, Y ; qk)] = 0




k=1 q̂kI{r(S,T,Y )=k} can be shown to have the form:
IF†t (O;µ
∗
t , α̃, η̃) = IFt (O;µ
∗













∂Uk(S, T, Y ; qk)
∂qk
]−1
Uk(S, T, Y ; qk)
=
V
q(S, Y, T )
h1t (X, Y, T ;µ
∗
t , α̃, η̃) + h2t (S, Y, T ;µ
∗




q(S, Y, T )
− 1
}
E [h1t (X, Y, T ;µ
∗
t , α̃, η̃)| r(S, Y, T )] ,
(3.7)
where either α̃ = α∗ or η̃ = η∗.
Note that IF†t (O;µ
∗
t , α̃, η̃) is exactly IFt (O;µ
∗
t , α̃, η̃) minus its projection
onto the space spanned by {Uk(S, T, Y ; qk) : k = 1, . . . , K}. By the triangle
inequality, it can be shown that IF†t (O;µ
∗
t , α̃, η̃) will have a smaller variance
than IFt (O;µ
∗
t , α̃, η̃). The associated asymptotic variance of an estimator of µ
∗
t











q(S, Y, T )
Var [h1t(X, Y, T ;µ
∗








Var [h1t(X, Y, T ;µ
∗
t , α̃, η̃) r(S, Y, T ) = k]P [r(S, Y, T ) = k] + C
†
t
for some constant C†t that does not depend on q(S, Y, T ). Thus, minimizing the





Var [h1t(X, Y, T ;µ
∗
t , α̃, η̃) r(S, Y, T ) = k]P [r(S, Y, T ) = k] (3.8)
over q1, . . . , qK .
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3.2.2 Optimizing the choice of qk
We are interested in finding the optimal q(S, Y, T ) to draw inference about
µ∗t = E[Yt]. For a given estimator, our goal to find the choice of q(S, Y, T ) that
minimizes the variance of the estimator subject to sample size restrictions on
the validation sample. Formally, our goal is minimize either (3.2) for estimators
which treat q(S, T, Y ) as known or (3.8) for estimators which treat q(S, T, Y )
as unknown with respect to q(S, Y, T ), provided that the expected validation
sample size in treatment t is less than nt for t = 0, 1. The expected validation
sample size in treatment group t can be expressed as:
nE
[





qkP [T = t, r(S, Y, T ) = k].
















qkP [T = 0, r(S, Y, T ) = k] ≤ n0
0 ≤ q1, . . . , qK ≤ 1
(3.9)
To execution the optimization, the conditional expectation in (3.2) (or condi-
tional variance in (3.8)) and probabilities P [r(S, Y, T ) = k], P [T = 1, r(S, Y, T ) = k]
and P [T = 0, r(S, Y, T ) = k] need to be estimated. The probabilities can be es-
timated, using first stage data, by En[I(r(S, Y, T ) = k)], En[I(T = 1, r(S, Y, T ) =
k)] En[I(T = 0, r(S, Y, T ) = k)] respectively. We discuss estimation of the con-
ditional expectation in the next subsection.
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Intermediate step
The conditional expectation E
[
h1t(X, Y, T ;µ
∗
t , α̃, η̃)
2
∣∣ r(S, Y, T ) = k] in (3.2)
and conditional variance Var [h1t(X, Y, T ;µ
∗
t , α̃, η̃) r(S, Y, T ) = k] in (3.8) de-
pends on the conditional distribution of W given r(S, Y, T ) = k. This con-
ditional distribution cannot be estimated based on the first phase data. To
address this problem, we propose an intermediate step between the first and
second phases, where we collect data on the expensive covariates W from a small
subset of subjects in first phase. With this intermediate step, we would have n
independent and identically distributed copies of O(1) = (S ′, Y, T, V (1), V (1)W ′)′,
where V (1) is the validation indicator in the intermediate step, i.e. the indica-
tor of being selected into the small subset on which we collect W . We assume
the same stratification function is used. For all subjects in stratum k (i.e.,
r(S, Y, T ) = k), we assume the pre-specified probability of being selected into
the intermediate validation sample is q
(1)
k := P [V
(1) = 1|r(S, Y, T ) = k]. We





The advantage of the intermediate step is that the resulting observed data
O(1) are generated by an outcome-dependent two-phase sampling scheme and
we can use the techniques of Wang et al. (2009) to estimate µ∗t , α
∗ and η∗.




q(1)(S, Y, T )
ĥ1t
(




)2∣∣∣∣ r(S, Y, T ) = k] , (3.10)
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q(1)(S, Y, T )
ĥ1t
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q(1)(S, Y, T )
ĥ1t
(




)∣∣∣∣ r(S, Y, T ) = k]2 (3.11)
where En[·|r(S, Y, T ) = k] is the empirical expectation operator over the stratum
r(S, Y, T ) = k, (µ̂
(1)
t , α̂
(1), η̂(1)) are estimators of (µ∗t , α
∗, η∗) of based on O(1), and
ĥ1t is an estimator of h1t.
For the SIPW estimator, h1t is given by (3.4) and it can be estimated by
replacing ASIPWt (µt, α) with
ÂSIPWt (µt, α) = En
[
V (1)

















For the EDR estimator, h1t is given by (3.6) and it can be estimated by replacing
AEDRt (µt, α, η) and H
EDR
t (µt, α, η) with
ÂEDRt (µt, α, η) = En
[
V (1)
q(1)(S, Y, T )










ĤEDRt (µt, α, η) = En
[
V (1)
q(1)(S, Y, T )













Since the covariates W are valuable, it is important to incorporate the W ’s
collected in the intermediate step into the validation sampling at the second
phase. Specifically, we propose the following two-step procedure:
• If V (1) = 1, set V = 1; i.e. those subjects with W measured in the
intermediate step will directly be included as part of the validation sample
at the second phase.
• If V (1) = 0, generate, for subjects in stratum k (i.e., r(S, Y, T ) = k), V
with conditional probability q
(2)
k = P [V = 1|r(S, Y, T ) = k, V (1) = 0]; i.e.
the remaining subjects in the validation sample will be a random subset
from those not selected at the intermediate step.










Note that (3.12) implies that
q
(1)
k ≤ qk ≤ 1, (3.13)
where q
(1)
k is pre-specified. Restriction (3.13) should be added to the constrained
optimization to obtain the optimal qk’s. The validation sampling probabilities
in the second stage, q
(2)








In sum, we conduct optimization (3.9) with the following modifications:
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• estimates of marginal probabilities are replaced by estimates computable
from the first stage data
• conditional expectations and variances are replaced by estimates com-
putable using intermediate stage data
• constraint (3.13) is added
The solution to the optimization can be used to obtain q
(2)
k using (3.14). These
stratum-specific probabilities can then be used to sample additional validation
subjects. Inference can then proceed with the SIPW or EDR estimators with
the sampling weights treated as known or estimated.
3.3 Simulation study
To illustrate the finite sample performance of our proposed procedure, we con-
ducted a simulation study with 2000 runs, each with a sample size n = 2000.
We generated data under the following true data generating mechanism:
S = (S1, S2)
′, S1 ∼ Bernoulli(0.5), S2 ∼ Bernoulli(0.3) and W ∼ N (0, 1). The
three covariates were assumed to be independent. Given the complete covariate
vector X = (S1, S2,W )
′, T , Y1 and Y0 were generated as independent Bernoulli
distributed random variables with probabilities
P [T = 1|X] = expit(S1 + 0.2S2 + 0.8W )
P [Y1 = 1|X] = expit(S1 + 0.3S2 +W )
P [Y0 = 1|X] = expit(1 + 1.5S1 + 0.5S2 + 1.5W ).
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We then set Y = TY1 + (1−T )Y0. Under this data generation scheme, (S, Y, T )
contains only categorical components, and the first phase data naturally form
K = 16 strata.
We considered the following two scenarios for generating V within each stra-
tum so that approximately 50% of subjects from each treatment arm were se-
lected in the second phase.
• “Equal number per stratum”: P [V = 1|S, Y, T ] = qeq(S, Y, T ) so that the
expected number of individuals selected per stratum is set equal to the
minimum of the stratum size and the expected total selected divided by
the number of strata K.
• “Optimal”: P [V = 1|S, Y, T ] = qopt(S, Y, T ), with V generated by the
following 3 steps:
1. Generate intermediate V (1) with probability P [V (1) = 1|S, Y, T ] =
qeq(1)(S, Y, T ) so that approximately 25% subjects from each treat-
ment arm is selected in the intermediate step using the “equal number
per stratum” rule above;
2. Solve for the constrained optimal qopt(S, Y, T ) minimizing the asymp-
totic variance of the estimation procedure of interest (SIPW or EDR;
known or estimated weights);
3. If V (1) = 1, we set V = 1; else generate V according to the conditional
probability
P [V = 1|S, Y, T, V (1) = 0] = q
opt(S, Y, T )− qeq(1)(S, Y, T )
1− qeq(1)(S, Y, T )
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We compared the performance of eight estimation procedures: two estima-
tors (SIPW and EDR) each with four ways of handling q(S, Y, T ) (qeq known,
qopt known, qeq estimated - q̂eq , qopt estimated- q̂opt). We focused on the treat-
ment effect ∆∗ = µ∗1 − µ∗0. The corresponding estimator of ∆∗ is ∆̂ = µ̂1 − µ̂0.




1, α̃, η̃)− IF0 (O;µ∗0, α̃, η̃) ;
when the weights are estimated, the influence function for ∆̂ will take the form:
IF†1 (O;µ
∗




0, α̃, η̃) .
Methods developed in Section 3.2 are still applicable except that h1t(X, Y, T ;µt, α, η)
and h2t(S, Y, T ;µt, α, η) are replaced by the corresponding differences
h11(X, Y, T ;µ1, α, η)− h10(X, Y, T ;µ0, α, η)
and
h21(S, Y, T ;µ1, α, η)− h20(S, Y, T ;µ0, α, η)
respectively. The corresponding conditional expectation and variances in the
optimization are estimated based on the intermediate stage data using the same
ideas discussed above.
For each intended estimation procedure, once the sampling scheme was de-
termined in the second phase, we drew the validation sample accordingly, com-
puted the corresponding estimator and estimated its standard error based on
the influence function. We further constructed 95% Wald confidence intervals
accordingly.
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The true values µ∗1 = 0.6153, µ
∗
0 = 0.7839 and ∆
∗ = −0.1687 were de-
termined in one extra simulation with sample size 108. In the same simula-
tion, we also computed E[Y |T = 1] = 0.6831, E[Y |T = 0] = 0.6782, and
E[Y |T = 1] − E[Y |T = 0] = 0.0049, which indicates that our data generating
mechanism has strong selection bias.
Table 3.1: Simulation statistics for treatment effect (µ∗1 − µ∗0) estimators, under















SIPW (qeq) -0.559 27.2 27.6 55.6 95.0 100.0
SIPW (qopt) -1.346 23.7 24.2 42.2 94.3 100.0
SIPW (q̂eq) -0.088 21.1 21.6 27.4 94.7 100.0
SIPW (q̂opt) -1.808 19.5 20.0 15.4 94.3 94.8
EDR (qeq) -0.417 20.8 21.3 25.4 94.3 100.0
EDR (qopt) -0.016 19.1 19.8 13.6 94.3 99.7
EDR (q̂eq) 0.005 20.8 21.3 25.4 94.5 100.0
EDR (q̂opt) -2.233 19.1 19.3 9.1 93.9 99.4
† Loss of efficiency (%): defined as (1-RE)×100%, where the RE represents the relative efficiency
with respect to the same estimator (SIPW or EDR) with W collected on the entire sample,
computed using ratio of the Monte Carlo variances.
The results of the simulation study are summarized in Table 3.1. Across
the 2000 simulated datasets, we report the convergence rate (see seventh col-
umn); and among those converged, we report average bias, average of standard
error estimate, Monte Carlo standard deviation of parameter estimates, loss of
efficiency compared to the same estimator (SIPW or EDR) with W collected
on the entire sample, and coverage of 95% confidence intervals (second through
sixth columns, respectively). With the exception of SIPW estimator with q̂opt,
the convergence rate was greater than 99%. The bias for all the eight proce-
dures is small. Moreover, the average of standard error estimates (third column)
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agrees well with the Monte Carlo standard deviation of the parameter estima-
tors (fourth column), and the coverage of the estimated 95% confidence intervals
is close to their nominal level.
In terms of efficiency, the EDR estimator is at least as efficient as the SIPW
estimator. When V is generated “optimally”, we observe lower variability com-
pared to when V is generated using the “equal number per stratum” procedure.
This is true for both SIPW and EDR estimators, regardless of whether the
weights are known or estimated. This is particularly obvious when comparing
SIPW (qopt) to SIPW (qeq) - 12% ∼ 13% reduction in variability. For SIPW,
we can also see reduced variability when using estimated rather than known
weights - there is a 22% reduction in variability for the “equal number per stra-
tum” sampling procedure and a 17% for the “optimal” sampling procedure. For
EDR, there is no reduction. This is because there is no model mis-specification,
i.e. α̃ = α∗, η̃ = η∗. This implies that AEDRt (µ
∗
t , α
∗, η∗) = HEDRt (µ
∗
t , α
∗, η∗) = 0.
Thus, the influence function when treating the weights as known or estimated
are identical.
An important question is: how much efficiency is lost due to not collecting
W on the non-validation sample. To address this question, we compared the
Monte Carlo variances between each estimation procedure under two phase
sampling and the corresponding estimation procedure with W collected on the
entire sample. We computed the loss of efficiency (%), as shown in the fifth
column of Table 3.1. For reference, the Monte Carlo standard deviations for the
SIPW and EDR estimators were both estimated to be approximately 18.4 when
W was recorded on all subjects. For the SIPW estimator, the resulting loss of
efficiency ranges from 15% to 55%. For the EDR estimator, the resulting loss of
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efficiency is approximately 25% for the “equal number per stratum” sampling
scheme and 10-15% for the “optimal” sampling scheme.
3.4 Data analysis
Right heart catheterization (RHC) is a diagnostic procedure to evaluate how
well the heart is functioning in critically ill patients. The Study to Understand
Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT)
was an observational study in which data were collected on the outcomes, treat-
ments and predictive factors of seriously ill, hospitalized adult patients at 5
medical center in the United States (Connors et al., 1996). We analyzed data
on 5,735 SUPPORT patients, of which 2,184 (38.1%) had RHC within the first
24 hours after study entry. Overall, 66.6% patients survived beyond 30 days;
62.0% with RHC and 69.4% without RHC. This translates into a crude esti-
mate of the difference in 30-day survival for RHC vs. no RHC of -7.36%, (95%
CI: -9.90% to -4.83%; P < .001). Because of confounding by indication, it is
important to estimate an adjusted effect of RHC on 30-day survival.
Connors et al. (1996), using an expert panel, identified a list of pre-treatment
variables that were a priori considered to be predictive of the decision to treat a
patient with RHC. These variables (X) included: age, sex, race, education, in-
come, insurance, primary and secondary disease categories, admission diagnosis,
ADL and DASI scores two weeks prior to admission, resuscitation order, cancer
status, estimate of surviving 2 months, physiology component of APACHE III
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score, Glasgow Coma score, weight, temperature, mean blood pressure, respi-
ratory rate, heart rate, PaO2/FIO2 ratio, PaCO2, pH, WBC count, hema-
tocrit, sodium, potassium, creatinine, bilirubin, albumin, urine output, and
co-morbidities. They used these variables to build a propensity score model
(i.e., a model for P [T = 1|X]) and matched each patient with RHC, if possible,
to a patient who did not receive RHC based on the estimated propensity score
and disease category. Based on 1,008 matched pairs, they found that RHC
have a lower 30-day survival than not performing RHC, with an odds ratio for
mortality of 1.24 (95% CI: 1.03 to 1.49; P = 0.03).
Hirano and Imbens (2001) and Tan (2006) also analyzed these data to esti-
mate the causal effect of RHC, i.e. difference of 30-day survival had all patients
been treated with RHC vs. untreated with RHC. The two papers also found
that RHC had significant decreased 30-day survival compared to not perform-
ing RHC. Hirano and Imbens (2001) used a combination of outcome regression
adjustment and propensity score weighting. Under various model specifications,
they reported causal effects ranging from -6.8% to -4.8% (with standard errors
ranging from 1.2% to 1.6%). Under a propensity score model, Tan (2006) de-
rived a local efficient estimator which is optimal under correct specification of
an outcome regression model. He also developed a doubly robust version of
this estimator which is consistent and asymptotically normal if either the the
propensity score or outcome regression models are correctly specified. He care-
fully built a propensity score model for the RHC data, allowing for interactions
of covariates. He applied the two proposed estimators and reported, under var-
ious model specifications, causal effect estimates ranging from -5.2% to -4.0%
(with standard errors around 1.5% ∼ 1.6%).
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To illustrate our proposed methods, we implemented a hypothetical two-
phase sampling design on the RHC dataset. Like Hirano and Imbens (2001);
Tan (2006), we are interested in the causal effect of RHC on 30-day survival.
In the first phase, apart from the 30-day survival indicator (Y ) and the RHC
treatment indicator (T ), we considered the “inexpensive” covariates (S) to be
collected on all subjects from the following demographic and socioeconomic vari-
ables: age, sex, race, education, income and insurance. To identify stratification
factors, we fit a logistic regression with 30-day survival indicator as the outcome
and the inexpensive covariate candidates plus the RHC treatment indicator as
predictors. Age and income ( categorized as: under $11k, $11–$25k, $25–$50k,
over $50k) were significant predictors at the 0.05 level.
Given the first phase data, we classified all subjects into 32 strata formed by
dichotomized age (by median), four levels of income, 30-day survival indicator
and RHC treatment indicator. As in the simulation study, we considered the
“equal number per stratum” (called “equal” below) and the “optimal” validation
sampling schemes. The goal was to sample approximately 50% of subjects
within each treatment arm. We included 71 covariates that had no missing
data on all 5,735 subjects. All covariates, except age and income level (S), were
treated as expensive covariates (W ).
We implemented the eight estimation procedures described in our simulation





For the sake of computational stability, all models included an intercept and
the main effects of the 71 covariates (i.e., no interactions).
Our analysis results are summarized in Table 3.2. In addition to the eight
estimation procedures under the hypothetical two-phase sampling design, we
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Table 3.2: Causal effect of RHC on 30-day survival (%),





SE 95% CI P-value
SIPW (qeq) -7.05 2.59 (-12.12, -1.98) 0.006
SIPW (qopt) -6.88 2.07 (-10.93, -2.83) 0.001
SIPW (q̂eq) -8.61 2.60 (-13.70, -3.51) 0.001
SIPW (q̂opt) -5.23 1.95 (-9.06, -1.40) 0.007
SIPW (1) -5.50 1.53 (-8.50, -2.50) <0.001
EDR (qeq) -7.43 2.02 (-11.39, -3.47) <0.001
EDR (qopt) -6.38 1.83 (-9.97, -2.78) 0.001
EDR (q̂eq) -7.95 2.19 (-12.24, -3.66) <0.001
EDR (q̂opt) -5.46 1.83 (-9.05, -1.88) 0.003
EDR (1) -6.21 1.51 (-9.16, -3.25) <0.001
also show, for comparative purposes, the results of the SIPW and EDR esti-
mators using the expensive covariates W for the entire sample (i.e. sampling
probability q = 1), these latter estimators are labeled as SIPW (1) and EDR (1).
For each estimation procedure, we report the estimated causal effects of interest
(%) and associated standard error (SE), the 95% Wald confidence interval and
the two-sided p-value based on the Z-score.
For both the SIPW and EDR estimators, the estimated treatment effect
is larger (in absolute value) and closer to the crude estimate (-7.36%) under
the“equal” sampling scheme as compared to the “optimal” sampling scheme.
The estimates under “optimal” sampling range from -6.9% to -5.2%, closer to
the full estimates when W is collected on the entire sample. Under “equal”
sampling, the standard error is about 2.6% for the SIPW estimator and about
2.0% for EDR estimator. The comparable standard errors are lower under
“optimal” sampling (2.0% and 1.8%, respectively) and full sampling (1.5% and
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1.5%, respectively) . The SIPW and EDR confidence intervals under “optimal”
sampling are 23% and 10% shorter than those under “equal” sampling, and 25%
and 20% longer than those under full sampling. Estimation of the sampling
weights did not meaningfully reduce the standard errors. The SIPW and EDR
estimates and estimated standard errors under full sampling are comparable
with the results in Hirano and Imbens (2001) and Tan (2006). All estimation
procedures in Table 3.2 yield p-values less than 0.01, indicating significantly
lower 30-day survival for RHC treatment.
3.5 Conclusion and Discussion
In this paper, we studied the outcome-dependent two-phase sampling design for
estimating the causal effect of a treatment from observational data, and pro-
posed an algorithm to find the optimal stratum-specific sampling probabilities
for drawing the validation sample in the second phase. Our method aims at
minimizing the variance for pre-specified type of estimators subject to the con-
straint of the validation sample size. To estimate the variance, we propose an
intermediate step to collect information on the distribution of the expensive co-
variates conditional on the first phase data. An advantage of our methodology
is that data collected in the intermediate step not only serves as a pilot data
for estimation purposes, but also constitutes part of the final validation sample.
Our procedure makes maximal use of the data and incorporates sampling uncer-
tainty into the final estimation procedure. We also incorporated more efficient
versions of the Wang et al. (2009) estimators that rely on estimates of the sam-
pling probabilities. Our simulation study and empirical analysis demonstrated
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that our “optimal” sampling strategy is more efficient than an “equal number
per stratum” sampling strategy.
In this paper, we assumed that the stratification function was pre-specified.
An open question is how to choose this function in order to further improve
efficiency. This is particularly difficult when the first phase covariates are high-
dimensional. We also pre-specified the intermediate validation sampling prob-
abilities. While larger sampling probabilities will ensure a better estimate of
the variance of a given estimator in the optimization, it constrains the amount
of sampling at the second stage (since subjects selected at the intermediate
step count toward the total number of validation subjects). It is an open ques-
tion as to the proper balance between the number of subjects sampled at the
intermediate and final steps.
The methods in this paper were developed within an independent and iden-
tically distributed (i.i.d.) observation framework. Some studies with two-phase
sampling designs may employ binomial sampling within strata, i.e. selection of
a specified number of subjects from each stratum. Future work could focus on








Two-sided confidence intervals for a parameter of interest that are based on
asymptotic normal approximations are second order accurate (i.e. with coverage
error O(n−1), where n denotes sample size). Equal-tailed two-sided bootstrap
confidence intervals, such as produced by bootstrap percentile, bootstrap-t (i.e.
studentized bootstrap) and bootstrap BCa also have second order coverage error
(Efron and Tibshirani, 1994; Tu and Shao, 1995; DiCiccio and Efron, 1996;
Davison and Hinkley, 1997). These intervals can have poor coverage in small
to medium sized samples.
The iterated or double bootstrap was proposed to reduce the coverage error
(Hall, 1986). This procedure involves a nested level of resampling to calibrate
the nominal level of the confidence interval. This idea has also been called boot-
strap calibration (Efron and Tibshirani, 1994; Tu and Shao, 1995) and bootstrap
prepivoting (Beran, 1987). The calibration operation can be repeatedly iterated
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to obtain higher order accurate confidence intervals. Hall and Martin (1988)
provided a unified account for the coverage correction of confidence intervals
in a general framework of bootstrap iterations, and showed that each iteration
reduces the coverage error by a factor of O(n−1). In practice, employing more
than one level of nested resampling is too computationally intensive to be of
practical use. In this paper, we focus the double bootstrap.
Double bootstrap itself is computationally intensive and there have been
a number of proposals to reduce its computational burden. Nankervis (2005)
proposed stopping rules to reduce the number of inner level bootstrap replica-
tions. Davidson and MacKinnon (2007) and Giacomini et al. (2013) suggested
the fast/warp-speed double bootstrap method that uses only a single simulation
at the inner level of resampling. Recently, Chang and Hall (2015) pointed out
that the coverage accuracy of the fast/warp-speed double bootstrap method
is not improved over single bootstrap resampling. Approximations to inner
level resampling have been investigated. Hall and Maesono (2000) introduced
a weighted bootstrap resampling approach to reduce the computational burden
while preserving the coverage accuracy. However, their method is complicated,
and can still be computationally prohibitive in medium-sized samples. DiCi-
ccio et al. (1992) introduced an easy and accurate saddlepoint approximation
(Daniels, 1954, 1987; Diciccio and Martin, 1991) to the bootstrap distribution
function that obviates the need for an inner level of resampling. A critical re-
quirement underlying the utility of their approach is that the estimator for the
parameter of interest is a smooth function of means of independent vectors.
In this paper, we extend the idea of DiCiccio et al. (1992) to more compli-
cated settings where the parameter of interest is the solution to an estimating
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function involve nuisance parameters. We propose to replace the original esti-
mator or its pivot with the corresponding influence function in the resampling
procedures, and calibrate the coverage error by using saddlepoint approximate
double bootstrap approach. Our idea of “resampling influence functions” was
inspired by Armstrong et al. (2014), where single layer bootstrap resampling
of the influence function was proposed in similar settings, and the correspond-
ing confidence intervals were showed to be consistent in coverage. Under mild
regularity conditions, we further show the second order accuracy of equal-tail
two-sided confidence intervals using their method, and improve the coverage ac-
curacy to at least third order, i.e. with error of order O(n−3/2), by saddlepoint
approximate double bootstrap.
Our methods are tailored to the case where the estimator for the nuisance
parameter is relatively hard to compute, but the influence function for the
estimator of the parameter of interest can be easily obtained. We take full
advantage of the properties of the influence function: firstly, estimators that
admit an asymptotic linear representation allow saddlepoint approximation to
the bootstrap resampling distribution; secondly, estimation of nuisance param-
eter is “borrowed” from the previous resampling level, and thus there is no need
for it to be re-computed for each resample replication. Consequently, our fast
double bootstrap algorithm is not only as speedy as most single layer bootstrap
procedures, but with even better confidence interval coverage accuracy.
The paper is organized as follows. Section 4.2 introduces the framework and
notation, gives a brief review of the iterated bootstrap procedures for construct-
ing equal-tail two-sided confidence intervals, and proposes the algorithm for our
influence function based fast double bootstrap interval. Section 4.3 establishes
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the third order accuracy of the proposed fast double bootstrap interval. A sim-
ulation study in Section 4.4 demonstrates that, compared to other methods,
our fast double bootstrap interval has desirable empirical coverage for small to
medium sample sizes. The final section is devoted to a discussion.
4.2 Framework and fast double bootstrap
Assume we have data from a random sample X = (X1, . . . , Xn) drawn from
some unknown distribution F indexed by a (scalar) parameter of interest µ and
a multi-dimensional nuisance parameter γ which belongs to a Banach space H
with a norm ‖·‖. To estimate µ, consider some smooth, unbiased estimating






where µ† and γ† are the true values for µ and γ, respectively. Suppose the





ψ(Xi;µ, γ̂(µ)) = 0, (4.1)
where γ̂(µ) is a profile estimator of γ based on sample X , for given µ. Assume
γ̂(µ) is a smooth function of µ, and γ̂(µ†) is
√
n−consistent. We are interested
in constructing an equal-tail two-sided bootstrap confidence interval (CIs) for
µ.
Let X ∗ denote a generic resample from X , and X ∗∗ denote a resample from
X ∗. Suppose we have B resamples X ∗1 , . . . ,X ∗B based on the X , and C sec-
ond level resamples X ∗∗b1 , . . . ,X ∗∗bC based on each bootstrap resample X ∗b (b =
1, . . . , B). Furthermore, for given µ, let γ̂∗(µ) and γ̂∗∗(µ) represent the versions
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of γ̂(µ) computed using X ∗ and X ∗∗, respectively, instead of X . Specifically, µ̂∗











0, respectively. We write µ̂∗b and µ̂
∗∗
bc to denote the corresponding versions com-
puted using X ∗b and X ∗∗bc (b = 1, . . . , B; c = 1, . . . , C), respectively. In addition,
γ can be estimated by γ̂(µ̂), γ̂∗(µ̂∗) and γ̂∗∗(µ̂∗∗) based on X , X ∗ and X ∗∗,
respectively. For simplicity, unless noted otherwise, we shall suppress such de-





































Figure 4.1: Diagram of double (iterated) bootstrap
The diagram in Figure 4.1 outlines the structure of double (iterated) boot-
strap resampling. Following DiCiccio et al. (1992), we hereby summarize the
double (iterated) bootstrap CI algorithm with coverage correction as follows:
• Denote the uncorrected CI of nominal coverage 1−α by I0 (α;X ,X ∗), e.g.




, where Q̃∗(x) is the
x-level quantile of the distribution of µ̂∗ given X , 0 < α < 1. Practically,
we plug in the empirical quantiles of {µ̂∗b ; b = 1, . . . , B.}
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• Define the coverage probability π(α) := P
[
µ† ∈ I0 (α;X ,X ∗)
]
.
• The bootstrap estimate of π(α) is computed by taking the sample X as
the population, using X ∗ and X ∗∗ in place of X and X ∗, respectively.
Practically, we plug in empirical average for probability where necessary
to obtain:















































where Q̃∗∗b (x) in (4.2) is the x-level quantile of the distribution of µ̂
∗∗ given
X ∗b .
• Note that the interval I0 (α + δn;X ,X ∗), where π(α + δn) = 1 − α, has
the exact coverage 1− α. We then find the bootstrap estimate δ̂n for δn,
as the solution to
π̂(α + δ̂n) = 1− α.
• The double (iterated) bootstrap CI for µ is
I1(α;X ,X ∗,X ∗∗) = I0(α + δ̂n;X ,X ∗).
To reduce the computational demands, DiCiccio et al. (1992) suggested that
the saddlepoint approximation to the cumulative distribution function (CDF)
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P [ µ̂∗∗ ≤ ·|X ∗b ] in (4.3) should be employed to replace the inner level of resam-
pling in (4.4). This “shortcut” only works for estimators which can be repre-
sented as a smooth function of means of independent vectors. Note, however,
that our estimator µ̂ is defined indirectly by solving the estimating equation (4.1)
which itself is the mean of dependent functions {ψ(Xi;µ, γ̂(µ)); i = 1, . . . , n}
sharing the profile estimator γ̂(µ). This motivates us to incorporate the asymp-
totic linear representation of the estimator, i.e. the influence function, into the
resampling procedures.
Assume the influence function IF(X;µ†, γ†) for µ̂ is readily available in our












†, γ†) + oP (1)
=
√
n · IF (X ) + oP (1), (4.5)
where






Notice that IF (X ) is the mean of independent and identically distributed ran-
dom variables, and thus can be used as an ideal substitute for the “centered
estimator” µ̂− µ† in the resampling procedures. Further, note that the influence
function may involve expectations with respect to the population distribution.
Define the following “bootstrap versions” of IF (X ):




ÎF(X∗i ; µ̂, γ̂) (4.6)
ÎF
∗









where ÎF(·) and ÎF
∗
(·) are the versions of IF(·) in which expectations are com-
puted conditional on X and X ∗, respectively. Intuitively, if we start with the
pivot
√
n(µ̂ − µ†), its bootstrap counterpart
√
n(µ̂∗ − µ̂) may be replaced by
√
n · ÎF(X ∗). The corresponding bootstrap confidence interval coverage can be
estimated and calibrated by double bootstrap concepts where the inner level
resampling is not actually necessary: the distribution of ÎF
∗
(X ∗∗) can be esti-
mated by a saddlepoint approximation to its density given X ∗. Note that in














∗, γ̂∗); i = 1, . . . , n
}
. We employ the following approxi-






(X ∗∗) ≤ x

















, where Φ(·) and
φ(·) are the standard normal distribution and density functions respectively,




2n {T ∗xx−K∗ (T ∗x )}
w∗x = T̂x
√
nK∗′′ (T ∗x )






















(K∗(T ) is the cumulant generating function of ÎF
∗
(X∗∗; µ̂∗, γ̂∗) given X ∗), and
the saddlepoint T ∗x is defined by K
∗′ (T ∗x ) = x. Note that in (4.8) above and
subsequently, we refer to P ∗ as the bootstrap distribution conditional on X .
Using this approximation, we revise the previous double bootstrap CI al-
gorithm accordingly, and propose the following influence function based fast
double bootstrap CI algorithm:
• Define the influence function based single bootstrap CI of nominal cover-
age 1−α as I0 (α;X ,X ∗) = [µ̂−Q∗(1− α/2), µ̂−Q∗(α/2)], where Q∗(x)
is the x-level quantile of ÎF(X ∗) given X , 0 < α < 1. Practically, we plug
in the empirical quantiles of
{
ÎF(X ∗b ); b = 1, . . . , B.
}
• Define the coverage probability π(α) := P
[
µ† ∈ I0 (α;X ,X ∗)
]
.
• The bootstrap estimate of π(α) is computed by taking the sample X as
the population, using X ∗ and X ∗∗ in place of X and X ∗, respectively.
Practically, we plug in empirical average for probability where necessary
to obtain:





























b(X ∗∗) ≤ µ̂∗b − µ̂
∣∣∣X ∗b ] ≤ 1− α2} (4.10)
where Q∗∗b (x) in (4.9) is the x-level quantile of the conditional distribution
of ÎF
∗
b(X ∗∗) given X ∗b and ÎF
∗
b(·) is the version of ÎF
∗
(·) based on X ∗b . The
conditional probability of ÎF
∗
b(X ∗∗) in (4.10) can be estimated using the
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saddlepoint approximation formula (4.8). Let π̃(α) denote the resulting
approximation for π̂(α).
• As in the previous version of the algorithm, interval I0 (α + δn;X ,X ∗),
where π(α + δn) = 1− α, has the exact coverage 1− α. We then find the
bootstrap estimate δ̃n for δn, as the solution to
π̃(α + δ̃n) = 1− α. (4.11)
• The fast double bootstrap CI for µ is I0(α + δ̃n;X ,X ∗).
4.3 Asymptotic coverage accuracy
We evaluate the coverage error of confidence intervals by the asymptotic accu-
racy, i.e. the convergence rate of the coverage probabilities of the confidence
intervals to the nominal level. A confidence interval I(α;X ) of µ† with nominal
coverage 1− α is said to be kth-order (asymptotically) accurate if
P
[
µ† ∈ I (α;X )
]





In this section, we derive the third order accuracy of our proposed fast double
bootstrap confidence interval.
As a prerequisite, we first establish the second order accuracy of the single
layer, uncorrected bootstrap confidence interval
I0 (α;X ,X ∗) = [µ̂−Q∗(1− α/2), µ̂−Q∗(α/2)], whereQ∗(x) is the x-level quan-
tile of the conditional distribution of ÎF(X ∗) given X . Here we follow the as-
sumptions and logic in Hall (1992) to derive the key points of the proof.


















As above, let σ̂∗2 and σ̂∗∗2 denote the bootstrap version of σ̂2 computed using
X ∗ and X ∗∗, respectively, instead of X . We assume the distribution of the
standardized pivot
√
n · IF(X )/σ† and the distribution of the studentized pivot
√
n(µ̂− µ†)/σ̂ admit the following Edgeworth expansions
P
[√






























uniformly in x, where uj(x) and ũj(x) are odd (even) polynomials for even (odd)
j. Moreover, suppose the following (inverse) Cornish-Fisher expansions hold:




















uniformly in ε < y < 1 − ε for any 0 < ε < 1
2
, where zy = Φ
−1(y), Qs(y) and
Q̃s(y) are the y-level quantiles of the distribution of the pivots
√
n · IF(X )/σ†
and
√
n(µ̂−µ†)/σ̂ respectively, and vj(x) and ṽj(x) are odd (even) polynomials
for even (odd) j. In particular, we have




the formulae in (4.16) also hold when uj, vj are replaced by ũj, ṽj respectively.
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The coefficients in the polynomials uj, ũj, vj, ṽj are functions of expectations
with respect to the population distribution. Write ûj, ̂̃uj, v̂j, ̂̃vj for the corre-
sponding versions in which these expectations are computed conditional on the
sample X . Under regularity conditions, we have the bootstrap version of the
quantile expansion (4.14):










where Q∗s(y) is the y-level quantile of the conditional distribution
√
n · ÎF(X ∗)/σ̂
given X . Meanwhile, we have for each 0 < y < 1,




, j = 1, 2.































































where p(x) is a polynomial whose coefficients are functions of expectations with
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respect to the population distribution, and
r1(x) = ũ1(x) + v1(x), (4.19)
r2(x) = ũ2(x) + v2(x)−
1
2
xv21(x) + v1(x) [ũ
′
1(x)− xũ1(x)] + p(x). (4.20)
The existence of p(x) requires some algebra (omitted) and the second to last
equality in (4.18) can be verified by a complicated argument presented in Hall
(1992). The last equality (4.18) follows from applying the Edgeworth expansion
(4.13) at x = zβ +
2∑
j=1
n−j/2vj(zβ) and employing a Taylor series expansion along
with the delta method to obtain the remainder of order n−3/2. It is useful to
notice that r1(x) is an even polynomial, since ũ1 and v1 are both even.
These results can be used to show that the influence function based single
layer bootstrap confidence interval I0 (α;X ,X ∗) = [µ̂−Q∗(1− α/2), µ̂−Q∗(α/2)]
has second order accurate coverage. Specifically,
P
[




























































= 1− α +O(n−1)
where the third equality follows by (4.18), the fourth equality follows because
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Next, we discuss the impact of bootstrap iteration for calibration and the
saddlepoint approximation on the coverage accuracy. To address this issue, we
use the general iterative bootstrap framework introduced by Hall and Martin




µ̂− t1 ≤ µ† ≤ µ̂− t2
}
− (1− α)
as a functional indexed by the pair (t1, t2). Constructing a (1− α)-level equal-






















where t(x) is the x-level quantile of some distribution; 0 < α, β < 1.















where Q∗(x) is the x-level quantile of ÎF(X ∗) given X . By (4.21), the associated
coverage error can be re-expressed as













The idea of coverage correction for this interval is to calibrate the level α in
−→
Q∗(α) so that the error is reduced to zero:







In practice, as stated in (4.11), we solve the bootstrap version of (4.25), i.e.,





















and Q∗∗(x) is the x-level quantile of the conditional distribution of ÎF
∗
(X ∗∗)












and assume dn converges to a nonzero constant as n→∞. Let ĉ0 and d̂n denote
the bootstrap estimates for c0 (see (4.22)) and dn respectively, conditional on









= OP (1) .













Therefore, the solution to (4.25) is





and similarly, the solution to (4.26) is






Rather than use π̂ to do the calibration, we use π̃ which is found by plugging
in the saddlepoint approximation to the conditional probability in (4.10). We
have the following relationship between π̃ and π̂:


















































































1− α + δ
2
)]








1− α + δ
2
)













for 0 < α + δ < 1, where P ∗∗ is the bootstrap distribution conditional on
X ∗, the third equality follows from the bootstrap version of the Cornish Fisher


















and the forth equality is a direct result by the delta method for Edgeworth
expansions.
Remember δ̃n is defined in (4.11) so that π̃(α + δ̃n)− (1− α) = 0. As with
(4.27), we deduce













Therefore, using the bootstrap Cornish-Fisher expansion (4.17) and Taylor se-










for any 0 < β1, β2 < 1.
Our calibrated fast double bootstrap confidence interval has the form:
I0(α + δ̃n;X ,X ∗) =
[
µ̂−Q∗(1− (α + δ̃n)/2), µ̂−Q∗((α + δ̃n)/2)
]
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Now, we can show third order accuracy as follows:
π(α + δ̃n)− (1− α)
= P
[







1− α + δ̃n
2
)






































































1− α + δn
2
)]













where the fourth equality follows by (4.28), the fifth equality follows by the
delta method of Edgeworth expansions and the last equality follows because
π(α + δn)− (1− α) = 0.
4.4 Simulation Study
We compared the finite sample coverage of confidence intervals computed using
our proposed fast double bootstrap method and other existing procedures in a
simulation study.
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We focused on estimating the causal effect of a treatment on an outcome
from observational data with the inverse probability weighted (IPW) estimator.
We define Y1 and Y0 to be potential outcomes under treatment 1 and 0, respec-
tively. In the observational study, we assume that we observe n independent
and identically distributed (i.i.d.) copies of X = (Z, T, Y )′, where Z is the co-
variate, T is binary treatment assignment indicator and Y = TY1 + (1 − T )Y0




To identify µ†t , we assume that T is independent of (Y1, Y0) given Z. To
estimate µ†t , we considered the widely used inverse probability weighted (IPW)
estimation approach. In this approach, a logistic regression model is specified
for P [T = t|Z], i.e.,





1 + exp {l(Z; γ†)}
.
where l(Z; γ) is a specified function of Z and γ. Under the identification and
modeling assumptions, it follows that
ψt(X;µt, γ) =
I {T = t}
ωt(Z; γ)
(Y − µt) , (4.29)
is an unbiased estimating function, where
ωt(Z; γ) =
exp {tl(Z; γ)}
1 + exp {l(Z; γ)}
That is, E[ψt(X;µt
†, γ†)] = 0.
Given data on a sample X = (X1, . . . , Xn) where Xi = (Zi, Ti, Yi)′ (i =
1, . . . , n), the nuisance parameter γ can be estimated by solving the score equa-





Sγ(Ti, Zi; γ) = 0,
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where the score function
Sγ(T, Z; γ) =
∂l(Z; γ)
∂γ
{T − ω1(Z; γ)} .





ψt(Xi;µt, γ̂) = 0.
It can be shown that µ̂t is a regular and asymptotically linear (RAL) estimator























The causal effect µ†1 − µ
†






In our simulation study, we generated data as follows:
• Z is drawn from a mixture distribution where
Z ∼
{
Unif(−1, 1) with probability 0.8
1 with probability 0.2
• Given Z, the three variables T , Y1 and Y0 are independently distributed
as
T ∼ Bernoulli (expit {−3.5Z})
Y1 ∼ N (Z, 0.0016)
Y0 ∼ N (1 + 1.5Z, 0.0016)
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Under the above settings, µ†1 = 0.2, µ
†




0 = −1.1. Notice that
the model P [T = 1|Z] was correctly specified in such way, with the true value
γ† = (0,−3.5)′. Under these assumptions, P [T = 1] = 0.406.
We considered the following five types of (1 − α)-level equal-tail two-sided
confidence intervals for each parameter of interest µ.
• Influence function based Wald type (IF):
[
µ̂− n−1/2σ̂z1−α/2, µ̂− n−1/2σ̂zα/2
]
;





is the x-level quantile of conditional distribution of µ̂∗ given X ;
• Single bootstrap-t (SB-t):
[
µ̂− n−1/2σ̂Q̃∗s(1− α/2), µ̂− n−1/2σ̂Q̃∗s(α/2)
]
,
where Q̃∗s(x) is the x-level quantile of the conditional distribution of
√
n(µ̂∗−
µ̂)/σ̂∗ given X ;





, where Q∗(x) is the x-level quantile of the conditional distribu-
tion of ÎF(X ∗) given X ;
• Influence function based fast double bootstrap (FDB):
[
µ̂−Q∗(1− (α +
δ̃n)/2), µ̂ − Q∗((α + δ̃n)/2)
]
, where Q∗(x) is the x-level quantile of the
conditional distribution of ÎF(X ∗) given X , and δ̃n is defined in (4.11).
In practice, the theoretical quantiles and probabilities needed in computing the
confidence intervals above were approximated by the corresponding empirical
estimates, based on the B resamples X ∗1 , . . . ,X ∗B from X . There is no need for
any inner-level resamplings. Only the fast double bootstrap has third order
accuracy; the remaining procedures are second order accurate.
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To illustrate the coverage accuracy and its convergence speed (to nominal
level) for various confidence intervals under different choices of sample size, es-
pecially for small to medium samples, we set the sample size n = 200, 500 and
1000 successively, and for each of the three sample sizes we simulated 5000 data
sets. Given each data set X = (X1, . . . , Xn), B = 5000 non-parametric multi-
nomial bootstrap resamples were drawn, i.e. X ∗ = (X∗1 , . . . , X∗n) i.i.d. from the




1 {Xi ≤ x}. We then constructed 95%
and 90% equal-tail two-sided confidence intervals using each of the five proce-







Finally, the empirical coverage of each choice of confidence interval (over pos-
sible procedures, nominal levels, and target parameters) was computed across
the 5000 simulated data sets, for each sample size. The results are presented in
Table 4.1.
It is important to notice that by the simulation design, the treatment as-
signment probability ωt(Z; γ
†) = P [T = t|Z] has very small value when the
covariate Z approaches its minimum at -1 or maximum at 1:
P [T = 1|Z = 1] = P [T = 0|Z = −1] = expit(−3.5) = 0.029,
which makes the inverse probability weight large for certain observations in the
IPW estimating function (4.29). It is well known that large weights can lead to
unstable performance of the IPW estimator especially when the sample size is
insufficient for the asymptotic normal approximation to work satisfactorily. We
expect this to happen for both treatment arms in our simulation.
In general, Table 4.1 lends support to the higher order coverage accuracy
of our fast double bootstrap confidence interval procedure. For both 95% and
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Table 4.1: Comparison of empirical coverage probabilities for various equal-tail
two-sided confidence interval (CI) procedures, with increasing sample sizes
Sample size Procedurea
95% CI coverage (%) 90% CI coverage (%)
µ1 µ0 µ1 − µ0 µ1 µ0 µ1 − µ0
200 IF 81.5 82.3 84.2 77.6 77.5 79.2
SB-p 83.5 85.0 83.7 79.6 79.9 78.5
SB-t 86.0 86.8 87.5 81.8 81.0 82.6
SB-IF 79.7 81.1 82.1 75.8 76.2 78.0
FDB 85.3 88.1 90.0 82.2 82.9 85.9
500 IF 91.8 89.5 90.8 86.4 84.3 85.0
SB-p 92.9 90.6 90.4 87.7 85.3 84.6
SB-t 94.3 91.9 93.0 91.1 86.9 88.2
SB-IF 89.5 88.1 89.0 84.9 83.4 83.7
FDB 94.7 92.5 94.5 90.7 87.6 89.4
1000 IF 93.2 92.2 92.7 88.1 87.5 88.2
SB-p 94.1 92.8 92.8 88.9 88.1 88.1
SB-t 95.2 94.5 93.6 90.7 89.8 88.5
SB-IF 92.3 91.0 91.8 87.2 86.9 87.6
FDB 95.5 94.6 94.6 90.2 89.5 89.9
a Procedures: influence function based Wald type (IF), single bootstrap per-
centile (SB-p), single bootstrap-t (SB-t), influence function based single boot-
strap (SB-IF), influence function based fast double bootstrap (FDB).
90% nominal levels, the fast double bootstrap intervals tend to have smaller
coverage error than the other four types of intervals. The advantage is most




0. Though all five procedures yield
coverage lower than nominal levels at sample size 200, the fast double bootstrap




0 by sample size
500, and for µ†0 by sample size 1000. Among the other four procedures, the
SB-t intervals outperform the other procedures. The influence-function single
bootstrap performed poorly, which emphasizes the need for calibration.
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4.5 Conclusion and discussion
In this paper, we proposed the fast double bootstrap confidence interval based
on influence function resampling and saddlepoint approximation methods. Our
procedure yields equal-tail two-sided confidence intervals of third order accuracy,
without inner-level resamplings.
The simulations indicate that our fast double bootstrap intervals are more
reliable than other widely used intervals like Wald type, bootstrap percentile or
bootstrap-t for small to medium sample size where asymptotic normality fails
to provide a reasonable approximation. Given the same computational burden
as most single layer bootstrap methods, our technique is economical and easy
to apply, while full implementation of the double bootstrap procedure can be
prohibitive.
For simplicity, we have assumed the parameter of interest is scalar. How-
ever, our approach is readily generalizable to vector valued parameters. Our
investigation of coverage accuracy relied on Edgeworth and Cornish-Fisher ex-
pansions, which requires the nuisance estimator γ̂ to be
√
n-consistent. This is
typically true for parametric models. However, in most semi-parametric models
where the nuisance parameter is estimated using non-parametric methods or
complex (e.g. sequential) procedures, it may only be estimable at rates slower
than
√
n. An important direction of future research is higher order asymp-
totics and bootstrap convergence rate of semi-parametric estimations when the






In this dissertation, we developed statistical methodology using influence func-
tions, under various sampling designs. We demonstrated the power of influence
functions as an inferential tool:
• In causal inference for comprehensive cohort studies, we found efficient
estimators under certain modeling restrictions by investigating the geom-
etry of the class of influence functions. We derived the properties of the
resulting estimators, like robustness to model misspecification, through
investigation of the corresponding influence function.
• In optimal outcome-dependent two-phase sampling design, the asymptotic
variance of the estimators under discussion, as the target to be minimized,
was accessed using their influence functions. The problem was tackled by
identifying the key component in the influence function which determines
the relationship between the sampling fractions of interest and the asymp-
totic variance of the resulting estimator.
• In the fast double bootstrap procedure, we replaced the pivot of the orig-
inal estimator with its asymptotic linear representation of the influence
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function in the resampling process. This shows how the influence func-
tion can be used to approximate the asymptotic behavior of the estimator
under discussion. Furthermore, the representation of the estimator as
an average of independent and identically distributed influence functions
allows us to apply many of the existing methods (e.g. saddlepoint approx-
imation), and therefore is more tractable compared to using the original
estimator.
In summary, statistical inference based on influence functions is widely appli-
cable in biomedical and public health research. The topics discussed in this
dissertation suggest enormous power and potential of the the influence func-
tions as inferential tools, which can be further exploited in future research.
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